TSS:Rfhg 135487.1

Basic information about the TSS

---

TSS ID: rfhg_135487.1 Species: human Chr: chr11		Start: 32090886 End: 32090908 Strand: +
Source datasets	DRA013844
Protocol	CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	PLS,CTCF-bound (EH38D2438358,EH38E1530386)
Category:	PLS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: AK129791:0 GeneID: 5954 HGNC/MGI_ID: HGNC:9934 UniProt_ID: Nearer transcript ids and distances: BC010120:154 ENST00000054950.4:166 NM_002901.4:166 D42073:237 FJ224346:237 CU679627:289 DQ892928:289 DQ896177:289 KJ891990:289 view more...

Gene_name: reticulocalbin 1 Gene_symbol: RCN1 Gene_synonyms: FLJ37041 PIG20 Rcal Gene_source: HGNC:9934

TATA-Box annotation

---

Distance to TSS:	-177
Nearest PromoterID:	NM_002901
Entrez ID:	5954
Nearest Unigene:	Hs.97887
Nearest Refseq:	NM_002901
Nearest Ensembl:	ENSG00000049449
Gene Name:	reticulocalbin 1
Gene Alias:	HEL-S-84|PIG20|RCAL|RCN
Gene Type:	protein-coding
CpG%:	0.136364
GC%:	0.739130
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@RCN1 p2@RCN1 p3@RCN1 p4@RCN1 p5@RCN1 p6@RCN1 p7@RCN1
Sample		p1@RCN1	p2@RCN1	p3@RCN1	p4@RCN1	p5@RCN1	p6@RCN1	p7@RCN1
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	21.23	10.13	4.09	15.78	2.14	1.36	0.58
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	24.89	10.12	4.45	19.42	2.23	1.62	0.61
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	25.66	6.75	3.47	16.98	0.77	1.54	0.39
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	17.67	8.73	1.87	13.31	1.04	1.04	0.62
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	22.05	6.52	3.15	17.32	2.02	0.67	0.67
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	18.99	7.95	2.52	14.34	2.52	0.78	0.78
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	22.44	10.02	6.10	15.25	3.49	1.96	1.09
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	23.01	11.14	1.94	19.38	1.45	0.24	0.24
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	23.72	8.33	3.63	19.02	1.50	1.50	0.43
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	26.66	9.27	2.32	26.08	2.32	1.16	1.16
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	21.83	5.26	2.02	23.45	1.21	0.40	0.40
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	28.87	10.98	4.88	17.89	1.63	0.41	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	39.49	17.73	3.87	6.77	7.09	3.06	1.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	41.20	11.28	3.61	4.21	4.21	2.26	1.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	37.76	17.34	5.05	6.81	5.27	4.39	1.54
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	39.48	14.84	4.53	6.04	5.78	1.51	0.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	38.66	11.58	4.59	9.61	3.49	3.93	0.87
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	39.65	11.81	5.48	5.06	7.17	0.84	1.69
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	27.72	6.93	1.60	11.20	1.60	2.67	1.07
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	32.65	11.43	4.66	5.12	5.27	2.11	1.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	34.08	13.23	4.41	5.21	4.54	2.27	1.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	31.42	13.46	4.14	5.70	6.04	2.07	0.69
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	34.38	12.15	4.01	4.52	4.27	2.33	1.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	34.94	11.41	4.61	6.07	4.85	1.70	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	36.63	15.48	5.42	6.97	5.93	1.03	2.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	31.65	13.61	4.43	5.06	4.75	1.27	2.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	36.26	8.79	2.20	13.19	3.85	0.55	2.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	35.83	10.84	5.19	3.77	5.42	3.54	1.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	34.24	8.72	4.85	3.39	3.55	2.58	1.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	33.48	12.67	4.71	7.78	4.34	3.26	0.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	36.01	13.40	3.77	4.81	6.70	1.47	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	36.93	14.65	5.67	6.06	6.25	2.54	0.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	35.24	10.34	3.38	5.49	4.64	1.48	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	30.35	7.75	1.81	4.29	2.97	1.32	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	36.28	12.15	4.49	6.36	4.11	1.87	0.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	40.43	12.46	4.98	6.52	7.28	2.49	1.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	32.70	11.45	4.70	4.50	4.29	2.25	1.02
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	33.04	15.72	5.24	6.04	6.85	2.82	1.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	38.89	13.24	6.21	8.10	6.21	1.89	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	34.81	14.16	4.32	6.24	4.32	1.92	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	33.88	9.18	5.41	8.00	6.35	1.65	1.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	34.26	9.52	4.68	5.42	2.49	1.90	1.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	40.28	17.72	5.69	6.54	5.27	3.16	1.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	36.19	12.76	4.55	7.34	6.47	2.80	2.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	43.17	13.85	5.02	7.43	4.82	2.41	1.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	37.46	12.56	4.19	7.91	5.12	3.02	1.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	42.94	10.56	3.60	7.44	8.88	3.12	2.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	31.30	13.71	6.56	8.94	5.66	2.98	1.79
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	39.26	13.64	3.83	9.34	4.07	3.83	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	30.94	11.12	2.22	8.09	5.66	2.02	1.01
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	29.51	11.27	4.51	7.58	2.87	1.84	0.82
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	37.80	15.34	2.89	8.89	3.34	2.22	1.78
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	167.91	55.97	27.98	27.98	41.98	13.99	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	38.32	13.13	5.32	8.16	3.55	2.84	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	42.75	18.23	3.31	11.93	3.65	3.65	1.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	46.14	11.75	3.36	17.62	4.19	3.36	1.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	28.47	6.89	2.30	10.56	3.67	0.46	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	40.51	19.12	5.19	11.67	4.86	2.92	1.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	38.86	19.91	4.82	11.56	3.85	3.21	3.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	30.80	7.54	4.09	10.69	4.71	1.26	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	47.24	16.92	4.94	11.28	3.53	2.12	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	44.86	15.70	4.49	11.22	2.24	3.93	2.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	27.07	7.17	0.00	14.33	3.98	2.39	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	29.22	7.47	2.38	8.83	3.40	2.04	1.02
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	53.94	22.42	4.87	14.30	4.87	4.22	1.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	48.99	22.01	6.03	14.55	4.26	5.32	2.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	274.79	64.66	16.16	113.15	16.16	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	260.62	23.69	15.79	86.87	15.79	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	49.24	18.04	6.83	17.06	2.44	2.44	1.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	59.50	13.39	4.46	20.33	3.97	2.98	2.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	48.79	17.83	4.22	23.92	2.35	3.28	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	44.38	16.23	2.65	16.89	3.64	1.66	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	64.34	27.22	4.33	24.75	4.33	4.33	2.78
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	64.51	27.21	2.45	24.77	4.28	4.89	1.53
Adipocyte - breast, donor1	11376-118A8	59.08	16.79	5.70	22.97	3.96	1.27	2.06
Adipocyte - breast, donor2	11327-117E4	37.22	10.91	4.49	16.04	3.05	1.12	0.32
Adipocyte - omental, donor1	11473-119C6	90.59	17.56	9.03	37.53	2.42	6.11	2.54
Adipocyte - omental, donor2	11474-119C7	40.36	11.21	3.74	25.41	4.48	3.74	1.49
Adipocyte - omental, donor3	11475-119C8	53.92	14.07	3.68	45.21	1.67	5.69	1.67
Adipocyte - perirenal, donor1	11476-119C9	65.08	21.05	3.83	34.45	5.74	4.47	0.64
Adipocyte - subcutaneous, donor1	11259-116F8	31.89	7.70	1.10	18.69	0.00	1.10	2.20
Adipocyte - subcutaneous, donor2	11336-117F4	51.94	12.65	6.32	25.74	1.35	3.16	1.81
Adipocyte - subcutaneous, donor3	11408-118E4	29.19	6.26	2.78	9.91	2.26	1.04	0.52
Adipocyte differentiation, day04, donor1	13019-139D4	140.62	28.16	23.47	41.85	4.69	9.58	4.50
Adipocyte differentiation, day04, donor2	13022-139D7	69.49	24.97	7.72	22.91	3.86	2.06	0.77
Adipocyte differentiation, day04, donor3	13025-139E1	100.08	29.27	11.43	50.18	5.30	2.51	2.51
Adipocyte differentiation, day04, donor4	13028-139E4	91.70	30.57	8.82	47.02	4.11	2.94	1.76
Adipocyte differentiation, day08, donor1	13020-139D5	74.64	11.98	7.64	25.10	2.57	3.14	0.97
Adipocyte differentiation, day08, donor2	13023-139D8	56.80	14.52	5.81	30.34	3.87	0.97	0.65
Adipocyte differentiation, day08, donor3	13026-139E2	41.59	12.26	3.73	16.53	1.60	0.00	1.07
Adipocyte differentiation, day08, donor4	13029-139E5	33.39	11.13	5.01	32.27	2.78	1.11	1.11
Adipocyte differentiation, day12, donor1	13021-139D6	34.52	13.31	7.90	22.46	2.91	2.08	1.25
Adipocyte differentiation, day12, donor2	13024-139D9	40.69	18.08	2.51	23.61	4.52	0.50	0.75
Adipocyte differentiation, day12, donor3	13027-139E3	31.42	10.80	3.60	26.18	3.27	0.98	0.98
Adipocyte differentiation, day12, donor4	13030-139E6	28.01	8.53	2.74	14.01	2.44	0.30	0.91
Alveolar Epithelial Cells, donor1	11510-119G7	28.07	7.29	3.09	9.94	1.77	2.21	0.88
Alveolar Epithelial Cells, donor2	11590-120G6	4.66	2.15	0.36	3.94	0.72	0.36	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	4.79	3.59	1.20	2.40	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	10.25	3.42	1.08	8.46	1.62	0.00	0.18
Amniotic Epithelial Cells, donor2	11613-122A2	21.76	3.35	0.00	5.02	0.00	0.00	1.67
Amniotic Epithelial Cells, donor3	11694-123A2	21.37	3.29	0.82	5.34	1.23	1.23	0.82
Anulus Pulposus Cell, donor1	11248-116E6	50.46	23.11	4.00	4.69	6.41	1.83	1.83
Anulus Pulposus Cell, donor2	11463-119B5	30.37	21.06	3.92	8.33	5.39	2.45	1.22
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	63.80	14.83	8.99	42.68	3.15	5.84	2.70
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	62.95	15.19	6.51	44.72	3.91	3.91	3.47
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	85.61	19.26	6.42	27.82	4.28	8.56	2.14
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	66.06	16.44	8.07	42.15	2.99	4.18	0.90
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	61.97	13.91	3.79	56.91	3.79	5.06	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	60.73	12.54	3.30	26.40	4.62	6.60	1.32
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	64.33	21.44	6.50	38.34	3.57	4.55	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	76.70	13.59	3.88	46.60	2.91	4.85	1.46
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	65.92	16.03	4.16	19.00	2.38	5.94	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	61.77	15.07	12.05	43.69	3.01	5.65	1.51
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	81.28	19.59	6.53	47.89	5.08	10.16	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	73.97	7.52	3.76	13.79	1.25	6.27	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	84.67	22.07	9.88	26.69	3.29	7.58	1.65
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	76.43	24.57	6.82	68.24	8.19	8.19	2.73
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	71.93	17.64	8.60	27.44	2.71	6.18	2.87
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	63.76	17.68	6.97	49.83	1.61	4.82	3.21
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	71.04	21.16	13.98	27.77	3.02	6.23	2.08
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	73.50	18.71	5.35	22.18	3.21	7.48	1.34
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	78.04	13.66	12.68	52.67	6.83	6.83	2.93
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	62.03	19.07	11.78	30.02	2.49	7.46	1.99
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	52.83	13.21	2.40	22.81	4.80	4.80	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	70.80	10.62	14.16	95.58	3.54	10.62	3.54
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	71.70	18.87	12.18	29.16	2.40	6.18	4.80
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	50.34	29.36	4.19	16.78	4.19	8.39	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	78.15	21.36	9.22	49.03	7.28	9.22	2.43
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	78.17	17.83	8.35	31.49	4.17	4.93	1.52
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	81.16	10.90	2.42	32.71	1.21	7.27	2.42
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	72.96	19.38	10.26	43.32	1.71	7.41	0.57
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	66.48	17.53	9.19	29.71	3.63	7.05	1.71
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	66.59	16.00	10.07	17.55	1.55	3.87	0.26
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	58.18	17.83	4.22	41.76	2.82	6.57	0.47
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	69.45	21.87	11.90	24.76	3.22	8.04	1.29
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	65.64	15.70	3.57	18.55	3.57	3.57	0.71
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	66.68	15.79	5.85	46.80	2.92	5.85	1.75
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	63.83	22.88	9.03	25.59	4.22	6.92	2.11
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	76.03	10.69	3.56	21.38	3.56	7.13	1.19
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	83.91	22.38	6.61	49.84	2.03	8.65	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	72.84	17.57	9.42	26.74	2.55	5.09	2.80
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	64.81	11.44	5.08	17.79	0.64	2.54	1.27
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	67.32	16.40	9.93	39.70	4.75	6.04	3.02
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	70.49	14.82	10.37	29.64	2.33	5.29	2.12
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	58.29	15.95	6.96	20.59	2.61	5.22	2.32
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	68.02	13.23	8.50	58.57	0.94	7.56	1.89
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	65.95	16.10	10.68	26.11	3.73	5.09	2.20
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	83.39	13.90	4.63	39.38	4.63	0.00	6.95
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	97.18	25.35	4.23	97.18	2.11	2.11	4.23
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	70.11	16.72	12.22	30.23	3.22	7.08	3.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	64.38	21.06	6.02	22.86	4.21	5.41	0.60
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	66.34	17.50	13.12	58.32	2.19	5.10	3.64
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	71.95	16.09	12.18	33.10	3.45	5.52	2.30
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	84.16	12.75	5.10	28.05	5.10	7.65	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	86.44	24.66	11.44	39.41	4.32	8.14	3.05
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	77.21	19.41	9.29	30.76	3.92	6.81	2.48
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	64.87	20.20	7.34	26.01	2.75	5.20	2.14
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	71.22	18.16	10.99	54.02	6.69	5.74	1.43
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	74.06	22.84	9.53	32.60	1.55	7.10	2.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	76.29	21.36	7.63	30.52	7.63	3.05	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	72.01	21.05	4.98	44.86	2.77	2.77	2.22
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	69.38	23.30	9.27	30.72	1.06	4.24	1.06
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	74.51	19.26	5.82	24.71	1.45	4.72	1.09
Astrocyte - cerebellum, donor1	11500-119F6	42.49	17.32	3.93	15.47	3.32	4.91	0.74
Astrocyte - cerebellum, donor2	11580-120F5	31.66	9.58	4.11	11.64	2.57	3.94	1.54
Astrocyte - cerebellum, donor3	11661-122F5	29.36	11.33	6.50	6.08	1.68	4.82	2.10
Astrocyte - cerebral cortex, donor1	11235-116D2	48.80	13.94	7.67	15.69	4.18	3.14	2.09
Astrocyte - cerebral cortex, donor2	11316-117D2	51.44	14.24	7.77	16.34	3.24	3.88	2.10
Astrocyte - cerebral cortex, donor3	11392-118C6	54.74	12.08	7.91	14.02	2.24	1.94	1.64
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	23.74	4.47	5.16	5.16	1.83	3.67	0.80
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	25.43	6.01	6.51	3.63	1.25	2.63	1.25
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	23.90	3.30	4.44	2.96	2.28	3.30	0.57
Basophils, donor1	12241-129G9	1.05	0.26	0.26	0.26	0.26	0.00	0.00
Basophils, donor2	12242-129H1	1.08	0.00	0.00	1.08	0.00	0.00	0.36
Basophils, donor3	12243-129H2	4.85	0.44	0.15	2.20	0.29	0.15	0.15
Bronchial Epithelial Cell, donor1	11511-119G8	7.76	2.37	0.43	5.17	1.08	0.22	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	2.29	1.37	0.00	0.46	0.91	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	21.52	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	7.53	1.88	1.88	2.51	0.00	1.26	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	4.57	1.66	0.62	2.08	0.42	0.00	0.21
Bronchial Epithelial Cell, donor6	11461-119B3	9.90	2.30	0.69	2.30	1.15	0.00	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	16.20	3.06	0.54	5.04	0.90	0.54	0.36
Burkitt's lymphoma cell line:DAUDI	10422-106C8	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Burkitt's lymphoma cell line:RAJI	10476-106I8	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	26.86	4.48	1.92	4.48	2.56	1.92	1.28
CD133+ stem cells - cord blood derived, pool1	12223-129E9	31.03	0.00	0.00	0.00	10.34	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	9.02	1.13	0.00	1.69	0.56	0.00	0.56
CD14+ Monocytes, donor2	11305-117B9	5.20	0.37	0.37	0.37	0.19	0.19	0.00
CD14+ Monocytes, donor3	11381-118B4	5.49	0.66	0.44	1.10	0.00	0.00	0.22
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	6.79	0.00	0.00	2.26	0.85	0.28	0.00
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	6.82	0.38	0.76	1.90	0.38	0.38	0.38
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	4.60	0.66	0.00	1.31	0.00	0.00	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	3.32	0.00	0.14	1.30	0.00	0.14	0.00
CD14+ monocytes - mock treated, donor2	11873-125C1	3.32	0.60	0.00	2.11	0.00	0.30	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	3.08	0.00	0.24	1.18	0.24	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	3.35	0.00	0.00	0.67	0.00	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	2.76	0.28	0.28	2.21	0.00	0.28	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	2.48	0.00	0.00	2.23	0.25	0.00	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	3.13	0.20	0.00	1.17	0.00	0.39	0.00
CD14+ monocytes - treated with BCG, donor2	11870-125B7	4.63	0.36	0.18	1.07	0.36	0.53	0.00
CD14+ monocytes - treated with BCG, donor3	11880-125C8	4.13	0.00	0.44	1.74	0.00	0.00	0.00
CD14+ monocytes - treated with Candida, donor1	11868-125B5	2.81	0.47	0.23	0.47	0.00	0.00	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	3.17	0.53	0.00	1.06	0.00	0.00	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	1.11	0.00	1.11	2.22	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	3.12	0.15	0.30	1.04	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	2.20	0.20	0.20	2.00	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	2.91	0.00	0.21	1.04	0.42	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	2.75	0.23	0.46	0.92	0.00	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	3.17	0.00	0.00	1.81	0.00	0.45	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	2.62	0.44	0.00	0.87	0.00	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	3.50	0.00	0.00	0.81	0.27	0.27	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	4.71	1.05	0.52	1.05	0.87	0.35	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	4.63	0.42	1.26	3.79	0.42	0.42	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	3.12	0.00	0.00	1.65	0.18	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	4.23	0.35	0.35	2.82	0.00	0.70	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	3.51	0.00	0.00	2.19	0.00	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	6.10	0.17	0.17	2.44	0.17	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	7.43	0.37	0.37	0.74	0.00	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	4.74	0.22	0.22	2.80	0.22	0.22	0.22
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	4.50	0.82	0.00	0.82	0.41	0.41	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	2.55	0.46	0.23	3.71	0.23	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	4.64	0.00	0.00	3.71	0.23	0.23	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	5.45	0.44	0.22	3.92	0.22	0.65	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	6.47	0.92	0.00	2.08	0.00	0.00	0.23
CD14+CD16+ Monocytes, donor3	11912-125G4	5.42	0.87	0.43	1.52	0.43	0.65	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	5.76	0.00	0.00	2.49	0.62	0.16	0.16
CD14+CD16- Monocytes, donor2	11799-124C8	6.11	0.52	0.17	1.57	0.52	0.35	0.35
CD14+CD16- Monocytes, donor3	11910-125G2	7.80	0.22	0.00	2.01	0.89	0.22	0.45
CD14-CD16+ Monocytes, donor1	11790-124B8	3.32	0.51	0.51	1.28	0.26	0.00	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	2.85	0.22	0.22	0.66	0.00	0.22	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	3.58	0.84	0.42	1.68	0.00	0.42	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	4.06	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	2.71	1.36	0.00	0.68	0.68	1.36	0.68
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	1.04	0.00	0.00	1.04	1.04	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	0.00	0.53	0.00	2.13	1.07	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	2.14	0.00	0.00	0.00	0.54	0.54	1.07
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	2.81	0.00	0.00	0.70	0.00	0.70	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	0.78	0.00	0.00	0.00	0.00	0.78	0.78
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	6.59	0.00	0.00	0.00	2.64	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	1.64	0.82	1.64	0.00	0.00	0.00	0.00
CD19+ B Cells, donor2	11624-122B4	2.90	0.00	0.73	0.73	0.00	0.73	0.00
CD19+ B Cells, donor3	11705-123B4	2.02	1.01	1.01	0.50	0.00	0.00	1.01
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	2.42	1.21	0.00	1.62	0.00	0.81	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	3.99	0.00	0.00	1.60	0.00	0.40	0.00
CD34+ Progenitors, donor1	11545-120B6	13.05	0.00	1.00	2.01	3.01	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	6.74	0.00	1.12	1.12	0.56	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	17.28	3.01	1.13	5.26	1.13	1.88	0.38
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	18.72	2.93	2.03	5.64	2.25	1.80	1.35
CD4+ T Cells, donor1	11225-116C1	1.43	0.00	0.00	0.36	0.71	0.36	0.00
CD4+ T Cells, donor2	11306-117C1	1.22	1.22	0.00	1.22	0.00	0.00	0.61
CD4+ T Cells, donor3	11382-118B5	1.83	0.61	0.00	0.61	0.00	0.00	0.30
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	2.30	1.02	0.00	1.53	0.51	1.28	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	2.47	0.67	0.00	0.67	0.90	0.45	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	4.60	0.57	0.29	0.00	0.29	0.29	0.29
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	0.95	0.95	0.00	0.00	0.47	0.95	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	1.40	1.40	0.00	0.00	0.70	0.70	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	1.88	0.14	0.29	0.72	0.00	0.43	0.14
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	2.37	0.85	0.17	0.68	0.17	0.34	0.17
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	3.06	0.32	0.32	1.77	0.64	0.64	0.48
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	1.79	0.00	0.90	0.45	0.00	0.45	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	0.70	0.35	0.00	0.70	0.70	0.35	0.35
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	0.88	0.44	0.00	0.44	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	2.11	0.42	0.00	1.26	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	3.12	0.42	0.00	0.62	0.00	0.42	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	2.00	0.33	0.33	1.34	0.33	0.67	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	2.45	0.54	0.27	1.63	0.82	0.82	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	2.68	0.54	0.00	0.54	0.54	1.61	0.54
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	0.00	1.79	0.00	1.79	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	4.64	0.74	0.37	1.85	0.19	0.56	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	3.25	0.22	0.00	0.87	0.43	0.43	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	5.46	0.21	0.42	1.26	0.63	1.68	0.42
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	1.01	0.51	0.51	0.51	0.00	1.01	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	0.43	1.30	0.00	0.00	0.87	0.00	0.87
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	2.18	1.31	0.00	3.05	0.44	0.00	0.44
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	5.94	0.00	0.49	2.47	0.00	0.99	0.49
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	2.77	0.00	0.92	0.92	0.00	1.85	0.92
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	9.77	1.40	0.00	1.40	0.00	1.40	1.40
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	2.77	0.83	0.28	1.94	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	4.42	0.25	0.00	0.98	0.25	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	3.08	0.00	0.00	3.08	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	3.58	0.00	0.36	1.43	0.36	2.15	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	2.77	0.00	1.38	1.38	0.00	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	3.27	0.65	0.65	0.98	0.33	0.00	0.00
CD8+ T Cells, donor2	11307-117C2	1.50	0.38	0.75	1.50	0.38	0.00	0.00
CD8+ T Cells, donor3	11383-118B6	5.81	1.26	0.76	0.25	1.01	0.50	0.50
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	18.35	1.61	0.23	9.63	0.00	0.92	0.46
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	18.21	0.96	0.24	9.35	0.48	0.72	0.00
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	19.15	0.82	0.55	7.39	0.27	0.00	0.27
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	21.01	0.90	0.60	14.11	0.00	0.30	0.30
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	18.24	0.48	0.72	7.44	0.48	0.24	0.24
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	13.64	0.68	0.91	10.91	0.45	0.23	0.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	11.52	0.65	0.22	8.47	0.00	0.00	0.22
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	10.79	1.58	0.00	5.26	0.00	0.26	0.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	13.84	1.64	0.47	11.73	0.23	0.47	0.94
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	11.47	0.30	0.91	9.36	0.00	0.30	0.00
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	13.65	0.87	0.87	6.97	0.29	1.45	0.00
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	16.52	1.33	1.07	6.39	0.53	0.27	0.00
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	15.32	0.88	0.00	12.26	0.00	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	8.65	1.37	1.37	17.31	0.00	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	10.44	2.24	0.75	13.43	0.00	0.00	0.75
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	20.53	1.44	0.36	11.16	0.36	0.36	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	18.99	0.86	0.00	10.93	0.00	0.58	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	15.56	0.47	0.71	8.25	0.24	0.71	0.47
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	16.48	0.32	0.95	11.73	0.00	0.32	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	12.92	0.92	0.62	13.53	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	15.07	0.00	0.64	9.30	0.00	0.64	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	11.47	0.38	0.38	13.00	0.00	0.00	0.38
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	11.43	0.79	1.18	10.64	0.39	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	10.59	2.27	0.00	12.86	0.76	0.00	0.76
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	16.06	0.00	0.00	12.85	0.00	0.00	0.80
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	13.29	0.70	0.00	9.09	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	13.02	1.00	1.00	14.02	0.00	1.00	0.00
Cardiac Myocyte, donor1	11525-119I4	84.08	34.73	0.00	21.93	7.31	0.00	1.83
Cardiac Myocyte, donor2	11605-120I3	51.39	9.39	5.93	31.62	0.49	2.96	0.49
Cardiac Myocyte, donor3	11686-122I3	79.35	18.10	13.15	26.73	2.84	2.84	2.84
Chondrocyte - de diff, donor1	11261-116G1	51.31	11.44	4.51	21.49	3.81	2.77	2.43
Chondrocyte - de diff, donor2	11338-117F6	21.32	12.79	1.07	12.79	2.84	1.42	1.07
Chondrocyte - de diff, donor3	11410-118E6	54.96	17.07	8.99	13.20	3.41	2.62	1.25
Chondrocyte - re diff, donor2	11339-117F7	34.91	12.53	2.69	22.38	0.90	3.58	0.00
Chondrocyte - re diff, donor3	11411-118E7	48.12	10.51	4.04	9.30	0.81	1.62	2.43
Ciliary Epithelial Cells, donor1	11242-116D9	80.22	20.20	18.25	14.23	4.25	8.03	4.48
Ciliary Epithelial Cells, donor2	11323-117D9	63.27	23.30	15.39	11.97	6.41	8.76	4.28
Ciliary Epithelial Cells, donor3	11399-118D4	59.47	17.35	16.20	9.20	2.39	6.19	3.81
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	13.30	3.58	0.92	3.58	1.74	1.65	0.55
Corneal Epithelial Cells, donor1	11526-119I5	12.30	2.85	0.66	4.17	1.76	1.10	0.44
Corneal Epithelial Cells, donor2	11606-120I4	5.69	1.14	1.14	1.14	2.28	0.00	1.14
Corneal Epithelial Cells, donor3	11687-122I4	19.17	1.53	0.00	3.32	1.02	0.51	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	6.27	1.16	0.50	1.49	0.17	1.32	0.00
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	6.94	0.63	0.63	0.95	1.26	0.63	0.32
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	0.00	0.00	0.00	6.90	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	5.08	1.19	0.76	0.76	0.54	0.86	0.22
Dendritic Cells - plasmacytoid, donor1	11228-116C4	4.10	2.05	1.02	0.00	0.34	1.37	0.34
Dendritic Cells - plasmacytoid, donor2	11309-117C4	5.22	3.26	2.61	0.00	0.00	1.96	0.65
Dendritic Cells - plasmacytoid, donor3	11385-118B8	2.90	1.45	0.48	0.00	0.00	1.94	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	47.36	5.34	5.84	8.51	1.83	1.50	1.00
Endothelial Cells - Aortic, donor1	11263-116G3	44.59	8.80	5.28	17.60	0.59	1.76	0.59
Endothelial Cells - Aortic, donor2	11340-117F8	63.35	9.05	8.77	35.92	1.70	1.41	0.85
Endothelial Cells - Aortic, donor3	11412-118E8	49.93	9.83	7.86	11.40	1.97	2.75	1.57
Endothelial Cells - Artery, donor1	11264-116G4	36.07	14.25	8.14	16.29	1.75	0.87	1.75
Endothelial Cells - Artery, donor2	11341-117F9	64.70	12.94	14.35	16.94	1.88	2.82	1.65
Endothelial Cells - Artery, donor3	11413-118E9	41.37	8.59	6.31	10.17	1.93	2.98	1.58
Endothelial Cells - Lymphatic, donor1	11236-116D3	74.70	11.97	12.41	17.95	1.99	3.77	3.99
Endothelial Cells - Lymphatic, donor2	11317-117D3	66.03	11.26	16.43	13.69	2.13	5.48	0.91
Endothelial Cells - Lymphatic, donor3	11393-118C7	69.35	8.18	11.28	22.27	3.10	1.13	2.26
Endothelial Cells - Microvascular, donor1	11265-116G5	31.79	5.35	4.16	12.48	2.08	2.67	0.89
Endothelial Cells - Microvascular, donor2	11342-117G1	30.72	6.25	1.56	15.62	0.52	0.52	1.04
Endothelial Cells - Microvascular, donor3	11414-118F1	25.95	2.69	5.10	5.10	1.42	1.70	0.57
Endothelial Cells - Thoracic, donor1	11266-116G6	98.03	17.21	9.60	57.22	2.00	5.20	1.20
Endothelial Cells - Thoracic, donor2	11343-117G2	48.74	8.91	14.15	16.25	0.52	0.00	1.57
Endothelial Cells - Umbilical vein, donor1	11243-116E1	101.88	10.19	15.03	21.87	2.86	3.98	1.86
Endothelial Cells - Umbilical vein, donor2	11324-117E1	61.05	5.87	7.60	18.03	1.30	3.26	1.96
Endothelial Cells - Umbilical vein, donor3	11400-118D5	66.93	11.48	14.53	19.42	2.93	3.42	1.95
Endothelial Cells - Vein, donor1	11267-116G7	37.54	9.10	12.51	25.03	2.28	1.14	2.28
Endothelial Cells - Vein, donor2	11344-117G3	46.10	8.38	9.08	33.53	0.70	1.40	1.40
Endothelial Cells - Vein, donor3	11416-118F3	53.38	12.25	13.50	15.54	1.57	2.36	2.51
Eosinophils, donor1	12244-129H3	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	1.65	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor3	12246-129H5	0.00	0.00	3.57	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	10.51	2.44	0.00	4.64	0.49	0.24	0.24
Esophageal Epithelial Cells, donor2	11587-120G3	6.24	2.08	0.00	10.40	6.24	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	60.35	18.06	8.62	26.68	1.23	3.69	0.82
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	43.25	17.96	6.90	20.26	2.19	4.82	2.08
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	12.24	20.15	2.93	2.17	5.09	1.73	1.19
Fibroblast - Aortic Adventitial, donor1	11245-116E3	76.77	14.67	7.76	20.86	2.43	3.27	2.18
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	95.26	9.28	10.78	25.93	1.77	3.82	1.09
Fibroblast - Aortic Adventitial, donor2	11326-117E3	82.48	22.04	13.92	19.09	3.27	8.65	3.06
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	125.42	5.80	12.12	84.58	1.84	2.37	2.11
Fibroblast - Aortic Adventitial, donor3	11401-118D6	57.80	16.28	9.63	17.61	2.66	2.99	1.00
Fibroblast - Cardiac, donor1	11268-116G8	41.73	9.98	5.44	18.15	2.27	4.08	0.91
Fibroblast - Cardiac, donor2	11345-117G4	31.08	4.55	1.52	15.92	1.52	5.31	0.00
Fibroblast - Cardiac, donor3	11417-118F4	42.11	8.52	6.31	13.72	1.58	2.37	1.58
Fibroblast - Cardiac, donor4	11452-119A3	92.14	27.89	12.73	25.46	2.42	4.85	2.12
Fibroblast - Cardiac, donor5	11456-119A7	78.68	14.21	7.87	24.24	3.05	3.93	2.16
Fibroblast - Cardiac, donor6	11460-119B2	62.15	16.52	6.52	26.07	2.58	2.73	1.36
Fibroblast - Choroid Plexus, donor1	11492-119E7	49.71	18.76	4.82	14.74	2.81	5.09	2.55
Fibroblast - Choroid Plexus, donor2	11572-120E6	46.16	19.41	7.33	10.79	2.16	5.61	1.73
Fibroblast - Choroid Plexus, donor3	11653-122E6	35.16	2.93	8.79	20.51	0.00	8.79	2.93
Fibroblast - Conjunctival, donor1	11531-120A1	70.81	20.53	11.30	27.68	5.54	6.69	1.15
Fibroblast - Conjunctival, donor3	11692-122I9	103.97	22.22	11.70	16.62	5.09	5.60	6.61
Fibroblast - Dermal, donor1	11269-116G9	51.18	13.38	8.45	16.20	3.52	3.52	1.64
Fibroblast - Dermal, donor2	11346-117G5	36.32	8.02	1.89	17.45	1.42	3.30	0.94
Fibroblast - Dermal, donor3	11418-118F5	69.99	13.18	8.46	13.30	4.11	2.06	0.97
Fibroblast - Dermal, donor4	11450-119A1	57.77	15.04	8.93	15.83	3.50	3.73	1.58
Fibroblast - Dermal, donor5	11454-119A5	62.28	12.56	6.11	20.41	2.27	4.88	1.22
Fibroblast - Dermal, donor6	11458-119A9	54.57	15.59	6.01	18.35	1.30	4.22	0.65
Fibroblast - Gingival, donor1	11237-116D4	88.91	20.61	9.37	28.11	3.96	3.75	1.67
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	50.57	7.07	4.98	13.36	1.83	1.83	1.31
Fibroblast - Gingival, donor2	11318-117D4	54.69	10.15	8.30	10.67	2.90	4.09	1.32
Fibroblast - Gingival, donor3	11394-118C8	102.00	26.98	13.83	26.59	5.12	3.29	3.19
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	88.31	18.70	16.62	27.01	3.12	1.04	4.16
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	69.25	16.03	6.70	19.03	3.35	1.59	1.94
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	55.66	7.02	3.74	12.16	2.49	3.43	1.40
Fibroblast - Gingival, donor6 (control)	11922-125H5	59.77	7.71	4.46	16.09	2.03	1.49	0.68
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	17.64	5.65	2.47	3.53	4.23	2.82	0.35
Fibroblast - Gingival, donor7 (control)	11924-125H7	71.51	10.38	4.83	14.62	2.92	2.78	0.73
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	39.41	6.14	2.05	10.50	2.86	1.64	0.82
Fibroblast - Gingival, donor8 (control)	11926-125H9	60.22	6.36	2.74	16.56	2.41	2.96	0.66
Fibroblast - Gingival, donor9 (control)	11927-125I1	86.58	23.77	8.36	17.46	6.02	4.26	1.76
Fibroblast - Lung, donor1	11270-116H1	21.75	5.44	1.36	1.36	4.08	1.36	0.00
Fibroblast - Lung, donor2	11347-117G6	67.15	10.45	5.97	28.35	1.49	4.48	0.00
Fibroblast - Lung, donor3	11419-118F6	59.30	15.83	14.35	6.75	2.53	2.74	1.69
Fibroblast - Lymphatic, donor1	11506-119G3	77.47	16.66	4.17	44.15	2.50	3.33	1.67
Fibroblast - Lymphatic, donor2	11586-120G2	41.96	19.58	1.40	39.16	2.80	1.40	1.40
Fibroblast - Lymphatic, donor3	11667-122G2	27.99	5.60	3.92	7.00	0.84	3.92	0.56
Fibroblast - Mammary, donor1	11540-120B1	112.45	23.14	11.77	38.97	2.84	8.93	1.22
Fibroblast - Mammary, donor2	11620-122A9	31.95	7.99	0.00	3.99	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	107.21	11.91	11.91	11.91	5.96	0.00	5.96
Fibroblast - Periodontal Ligament, donor1	11238-116D5	76.04	9.89	7.37	14.55	2.91	4.07	1.55
Fibroblast - Periodontal Ligament, donor2	11319-117D5	81.00	19.57	12.89	16.69	3.19	6.07	2.58
Fibroblast - Periodontal Ligament, donor3	11395-118C9	78.33	14.38	12.24	30.60	3.37	2.45	1.84
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	68.69	13.74	11.07	35.49	2.29	4.58	1.53
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	61.83	12.15	7.56	21.87	2.97	2.97	1.35
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	71.21	20.06	9.39	19.02	4.75	3.02	2.32
Fibroblast - Pulmonary Artery, donor1	11250-116E8	66.87	11.16	9.06	16.80	2.32	4.20	1.33
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	72.13	15.04	5.69	28.45	2.84	3.66	0.81
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	45.44	12.70	4.01	10.02	2.67	0.67	0.67
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	79.86	25.70	13.44	24.12	3.16	2.77	3.16
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	99.42	4.76	3.37	61.92	1.19	2.78	0.40
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	93.96	15.63	9.24	63.05	2.13	7.99	2.49
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	92.43	25.62	13.40	47.50	3.15	4.93	2.37
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	146.22	8.42	6.02	82.74	4.21	4.21	0.60
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	88.30	20.19	4.64	35.52	4.43	4.21	1.62
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	73.64	5.31	3.80	44.54	1.27	1.52	0.25
Fibroblast - skin normal, donor1	11553-120C5	84.17	13.13	6.07	49.06	2.13	6.23	1.80
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	141.16	5.61	7.22	48.92	2.01	2.41	0.60
Fibroblast - skin normal, donor2	11561-120D4	55.86	14.47	2.61	36.97	3.82	3.62	1.11
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	81.00	7.86	4.53	43.82	2.72	2.72	0.60
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	101.07	23.28	10.85	29.74	3.56	4.72	3.65
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	80.35	19.32	8.03	27.86	3.08	4.62	3.42
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	160.93	9.52	8.87	133.67	2.96	7.88	1.97
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	69.13	10.97	4.79	34.62	3.20	6.07	1.28
Fibroblast - skin walker warburg, donor1	11554-120C6	50.94	9.61	6.41	27.33	2.87	3.04	1.69
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	64.61	9.72	4.70	32.30	2.04	2.98	0.63
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	110.80	66.48	22.16	88.64	22.16	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	6.10	1.74	0.00	5.23	0.00	0.00	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	20.63	2.43	1.73	4.85	1.91	1.56	0.52
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	21.60	2.60	1.56	6.51	1.04	0.00	0.78
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	21.21	2.81	3.07	5.11	0.26	0.77	0.26
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	32.92	6.89	1.53	6.12	0.77	0.00	0.77
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	19.14	7.02	1.28	6.38	0.64	1.28	1.28
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	21.39	25.96	7.99	6.85	5.99	2.28	1.14
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	45.50	25.92	10.20	12.41	4.96	1.65	1.93
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	29.00	22.15	5.94	9.36	5.94	2.28	0.91
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	23.97	27.74	11.89	5.55	6.34	4.36	2.18
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	48.90	25.90	10.84	10.84	5.02	2.38	1.85
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	41.75	31.64	7.83	11.42	8.81	1.63	0.65
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	20.34	11.06	7.52	4.86	5.31	0.44	1.33
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	34.91	15.55	5.51	16.68	3.25	3.67	1.27
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	39.28	12.68	7.39	17.36	2.83	4.19	1.60
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	28.47	15.04	8.06	8.86	3.49	3.49	1.88
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	58.35	10.28	8.18	19.20	2.60	4.96	2.23
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	49.14	10.80	7.20	19.79	2.63	5.12	2.08
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	37.00	8.13	7.73	9.96	1.22	4.07	1.02
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	57.50	9.58	10.50	14.15	2.05	2.97	2.28
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	53.19	7.60	5.85	21.43	1.74	2.49	1.12
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	45.46	8.96	9.62	13.55	1.75	3.28	3.28
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	59.98	9.46	13.00	16.55	2.07	3.25	3.55
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	63.11	9.38	8.58	25.27	2.54	2.54	1.91
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	53.62	10.28	10.05	16.09	2.01	4.47	0.67
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	59.68	10.69	12.50	21.57	1.81	3.83	1.01
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	69.21	17.81	9.16	24.26	1.19	4.41	1.70
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	77.06	14.54	10.29	19.60	1.77	4.79	1.77
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	84.18	21.64	13.01	19.77	1.98	6.14	1.14
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	65.41	14.35	15.37	29.72	1.37	4.61	1.37
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	78.45	19.03	9.96	28.66	1.77	3.32	1.33
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	78.70	15.31	10.65	20.97	2.75	5.32	1.83
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	65.75	17.76	8.98	34.91	0.82	5.51	1.23
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	75.71	13.41	11.55	15.68	2.48	4.54	2.48
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	71.60	13.49	10.03	22.25	2.08	3.23	1.73
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	74.88	17.34	15.18	19.85	1.67	4.17	1.50
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	63.70	14.99	11.68	14.77	1.54	2.20	2.20
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	71.58	12.67	8.61	25.09	1.72	3.69	2.21
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	71.32	17.67	17.02	19.45	2.92	3.89	2.92
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	66.71	13.15	14.43	17.64	0.64	4.49	1.60
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	62.44	20.09	10.80	18.19	2.94	3.60	2.27
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	67.22	26.73	18.03	19.14	2.37	4.27	2.21
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	68.42	18.25	11.25	19.16	3.95	5.17	1.52
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	68.89	20.91	10.45	22.89	3.14	3.45	1.78
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	74.87	22.83	16.03	18.66	1.76	4.61	3.95
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	57.23	17.39	16.27	13.75	3.37	4.21	2.24
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	56.85	15.37	8.24	21.20	2.31	3.52	1.39
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	65.78	23.53	12.30	15.78	2.41	2.94	1.87
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	78.34	22.64	14.69	27.23	1.99	4.44	1.68
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	62.70	18.14	8.94	22.28	2.72	4.92	2.07
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	80.24	30.36	23.58	23.04	2.17	3.52	4.07
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	55.12	14.75	10.69	17.70	3.13	5.53	2.03
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	64.04	12.28	8.77	17.11	1.10	4.17	2.85
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	71.41	17.85	10.91	16.86	0.00	11.90	1.98
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	82.58	16.88	12.00	17.41	3.56	4.62	2.51
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	70.01	12.31	10.69	14.73	3.23	6.05	2.22
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	55.92	13.47	10.17	17.03	1.52	6.10	2.80
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	29.06	10.15	3.58	13.54	3.38	4.18	1.39
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	22.50	15.87	4.62	10.79	2.77	4.78	2.16
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	35.39	18.00	7.16	21.07	2.86	6.96	2.45
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	33.17	18.78	6.57	16.27	1.25	3.76	0.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	27.69	15.26	4.80	10.74	2.83	3.11	0.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	23.98	11.53	4.61	11.07	1.84	3.69	1.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	44.55	24.75	14.85	22.27	0.00	0.00	2.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	27.46	15.09	6.96	15.86	0.77	2.32	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	41.72	14.44	8.02	32.09	1.60	1.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	27.82	31.30	8.69	15.65	0.00	0.00	1.74
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	31.90	20.18	5.53	14.32	0.65	1.30	1.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	37.89	15.24	7.82	13.18	0.82	1.65	1.24
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	29.99	6.66	10.00	33.32	0.00	10.00	6.66
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	44.46	16.50	7.83	20.69	0.56	1.96	0.56
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	33.66	15.03	9.48	17.98	1.63	1.63	1.96
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	52.85	15.10	10.90	19.29	0.84	0.00	1.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	41.03	16.22	10.81	18.13	1.59	1.91	1.27
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	40.42	15.28	7.81	18.68	1.02	2.38	0.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	35.50	10.44	10.44	20.88	2.09	2.09	2.09
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	47.53	15.46	12.03	21.76	2.29	3.44	1.72
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	43.51	17.17	5.92	11.84	1.18	2.37	1.78
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	44.05	11.86	3.39	16.94	0.00	1.69	1.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	48.88	19.88	10.77	16.98	0.41	3.73	1.24
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	45.57	15.42	8.28	19.56	1.15	2.53	1.61
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	68.49	31.61	21.07	10.54	0.00	5.27	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	44.59	15.76	9.61	14.99	1.92	3.84	1.15
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	47.27	17.28	9.45	12.71	0.98	2.61	1.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	45.48	18.73	15.38	14.05	0.67	3.34	4.01
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	55.48	23.50	15.80	13.87	1.54	2.31	3.08
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	70.52	24.99	16.43	24.65	2.05	3.77	3.08
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	47.21	14.91	9.94	14.91	0.00	2.48	2.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	58.98	17.46	16.04	16.04	1.42	1.42	3.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	60.35	11.47	13.88	15.69	1.21	3.62	3.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	50.87	24.93	12.21	10.17	1.53	1.02	1.53
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	56.24	18.35	13.96	15.95	1.20	3.19	3.19
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	54.27	16.28	15.29	9.87	1.48	5.92	2.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	66.10	16.53	12.98	8.26	2.36	3.54	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	58.93	19.25	12.25	8.75	1.75	4.67	2.92
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	74.17	13.61	17.99	14.04	1.32	2.63	2.19
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	45.78	14.41	11.02	15.26	3.39	0.00	1.70
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	38.20	13.13	9.55	13.13	0.60	3.58	1.19
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	31.06	16.50	9.70	10.19	1.94	2.91	0.97
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	75.33	19.40	9.13	29.67	1.14	2.28	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	69.44	17.46	7.90	22.45	4.16	4.16	2.08
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	43.85	9.00	2.25	11.24	3.37	3.37	2.25
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	66.92	17.44	7.61	42.18	2.85	0.95	1.59
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	51.38	18.80	7.10	33.00	2.92	4.60	2.92
Hep-2 cells mock treated, biol_rep1	11898-125E8	29.94	6.61	2.44	9.05	2.44	1.51	0.58
Hep-2 cells mock treated, biol_rep2	11899-125E9	31.23	6.41	1.86	12.83	1.01	1.01	1.18
Hep-2 cells mock treated, biol_rep3	11900-125F1	31.85	6.83	2.96	10.47	1.82	2.05	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	32.57	6.78	3.28	8.74	1.42	2.30	0.33
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	25.36	7.09	2.58	10.75	1.72	1.72	0.21
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	36.81	6.03	2.15	11.19	1.08	2.58	0.22
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	33.00	5.85	3.74	7.47	2.49	1.62	0.25
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	21.96	3.77	2.23	8.41	1.54	1.03	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	27.23	4.49	3.20	8.01	2.24	0.96	0.64
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	29.10	6.72	5.04	14.55	2.24	3.92	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	28.56	3.90	1.73	9.52	0.43	0.87	0.43
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	42.30	23.79	7.93	26.44	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	56.44	15.87	10.58	17.99	2.12	4.59	2.12
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	38.51	7.27	5.09	7.27	1.45	3.63	2.18
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	51.40	8.92	7.17	18.36	1.57	1.92	1.40
Hepatocyte, donor1	11523-119I2	30.27	1.21	0.00	15.74	0.00	1.21	0.00
Hepatocyte, donor2	11603-120I1	36.63	2.15	1.08	12.93	0.00	0.00	0.00
Hepatocyte, donor3	11684-122I1	28.22	0.61	0.61	12.27	1.84	0.00	0.61
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	0.65	0.65	1.31	0.65	0.65	0.00	0.65
Intestinal epithelial cells (polarized), donor1	11246-116E4	17.65	3.32	1.05	7.52	1.92	0.35	0.17
Iris Pigment Epithelial Cells, donor1	11530-119I9	63.94	13.86	10.70	15.64	2.88	4.94	3.29
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	3.18	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	1.38	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	1.62	0.00	0.00	0.00	0.00	1.62	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	1.67	0.00	0.00	1.67	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	1.32	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	2.22	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	0.00	5.24	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	1.26	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	0.00	0.00	0.00	0.00	1.55	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	0.00	0.00	0.00	0.00	0.00	1.61	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	0.00	0.81	0.00	0.00	0.81	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	0.42	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	1.85	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	0.00	0.00	0.00	15.08	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	0.47	0.00	0.00	0.00	0.47	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	0.00	1.27	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	0.00	0.00	0.00	0.64	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	0.71	0.00	0.71	0.00	0.00	0.71	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	0.00	0.00	0.00	3.32	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	0.62	0.31	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	1.76	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	1.39	0.70	0.00	0.00	0.00	0.70	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	2.21	0.00	0.00	0.00	0.00	2.21	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	3.24	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	6.75	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	1.07	0.00	0.00	0.00	1.07	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	2.77	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	0.92	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	2.11	0.00	0.00	1.06	1.06	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	11.59	2.53	0.41	1.88	1.96	0.33	0.33
Keratinocyte - epidermal, donor2	11349-117G8	7.61	1.17	0.59	4.69	0.59	0.59	0.00
Keratinocyte - epidermal, donor3	11421-118F8	17.51	1.42	1.51	2.93	1.89	0.76	0.47
Keratinocyte - oral, donor1	11251-116E9	37.23	9.76	2.84	6.24	5.11	2.84	0.68
Keratocytes, donor1	11527-119I6	76.67	14.44	10.66	27.16	3.09	2.06	3.44
Keratocytes, donor2	11607-120I5	30.47	4.69	0.00	8.20	1.17	0.00	0.00
Keratocytes, donor3	11688-122I5	71.13	10.47	8.89	13.04	3.75	2.96	2.57
Krukenberg tumor cell line:HSKTC	10687-109F3	32.97	0.00	6.59	46.16	2.20	2.20	0.00
Lens Epithelial Cells, donor1	11529-119I8	71.20	9.71	8.63	17.26	4.31	6.47	0.00
Lens Epithelial Cells, donor2	11609-120I7	67.01	16.61	20.99	15.57	3.23	3.34	3.46
Lens Epithelial Cells, donor3	11690-122I7	117.06	18.57	15.54	29.47	2.72	8.38	4.54
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	55.97	10.67	10.79	13.99	2.02	2.96	1.90
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	42.14	7.54	5.58	13.95	1.95	1.95	1.12
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	62.81	8.66	8.19	22.35	1.57	2.99	1.10
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	52.16	7.53	4.30	27.42	2.69	1.61	1.08
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	35.30	7.25	5.99	13.24	0.32	2.52	0.32
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	29.22	6.15	4.42	10.24	1.40	1.51	0.65
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	64.84	11.90	8.21	27.09	1.23	3.28	1.23
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	24.78	3.79	2.78	6.32	0.76	1.26	0.51
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	33.50	6.62	4.50	11.54	1.27	1.97	0.84
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	42.72	7.12	7.12	28.08	1.19	1.19	0.40
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	44.01	8.92	6.40	15.51	1.74	1.16	1.94
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	18.70	3.70	3.52	6.30	0.93	0.37	0.37
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	47.04	11.85	5.57	24.39	0.35	1.74	1.05
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	42.93	7.16	6.44	18.84	0.72	2.15	0.72
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	29.39	5.49	5.49	10.99	0.96	1.65	0.41
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	64.67	13.55	11.70	31.72	1.54	3.39	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	20.89	4.36	4.05	5.30	0.62	1.87	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	33.85	4.94	4.94	10.25	2.20	1.65	0.37
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	54.30	9.22	6.58	25.01	0.99	1.32	1.32
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	27.53	2.93	2.93	7.91	0.59	0.88	0.59
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	21.66	1.99	2.49	7.97	1.49	1.00	0.25
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	50.44	9.21	8.24	28.13	0.97	1.94	1.45
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	37.43	3.77	5.92	16.16	1.08	2.15	0.27
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	41.02	8.78	4.84	17.26	1.21	1.82	0.76
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	43.55	8.29	7.26	27.48	1.04	2.59	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	55.28	7.12	6.70	18.64	1.05	1.47	0.84
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	34.74	4.51	4.81	12.48	1.35	1.35	0.45
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	46.09	8.94	4.82	32.33	0.69	1.38	0.69
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	40.64	7.34	6.77	13.17	2.07	1.51	1.13
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	29.16	5.62	4.03	9.75	0.74	0.64	0.53
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	47.97	10.66	9.69	28.11	1.45	3.88	1.45
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	32.75	4.63	5.62	12.90	1.32	0.99	0.66
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	29.73	5.08	3.72	11.15	0.74	1.73	0.62
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	60.34	11.85	7.40	21.84	0.74	2.22	0.74
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	43.73	4.69	7.17	13.59	0.00	1.24	1.73
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	25.99	3.85	4.67	9.76	1.10	2.75	0.55
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	54.04	11.26	8.68	29.27	0.64	2.89	1.29
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	45.95	7.61	5.78	16.74	1.22	1.22	0.30
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	50.67	7.42	7.42	19.18	2.10	2.66	1.12
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	50.85	10.31	6.04	24.18	0.00	3.20	1.07
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	17.94	2.91	1.45	11.15	0.00	0.97	0.48
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	21.79	2.96	2.02	7.16	0.31	0.78	0.16
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	52.28	11.82	7.88	29.72	1.07	2.51	2.15
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	32.34	5.23	6.21	15.68	0.98	0.98	0.98
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	19.54	4.00	2.12	9.65	0.24	1.18	0.24
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	53.21	9.65	8.91	17.20	0.99	2.23	1.24
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	22.80	3.84	5.38	11.27	0.77	2.05	0.26
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	34.01	5.67	4.18	12.53	0.30	1.19	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	0.00	0.00	2.27	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	3.07	0.00	0.77	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	0.74	0.74	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	1.27	0.42	0.00	0.42	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	1.41	0.00	0.70	0.70	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	0.00	0.93	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	0.00	0.52	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	1.19	0.00	0.00	0.00	1.19	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	2.04	0.23	0.00	0.23	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	0.87	0.29	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	1.35	0.45	0.45	0.45	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	1.49	0.27	0.00	0.14	0.00	0.14	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	0.51	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	0.71	0.71	0.00	0.35	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	0.00	2.00	0.00	0.00	0.00	0.00	0.67
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	0.51	0.00	0.00	1.53	0.51	0.51	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	1.33	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	1.32	0.38	0.19	0.38	0.00	0.38	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	0.61	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	1.63	0.00	0.00	0.82	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	1.04	0.21	0.00	0.21	0.00	0.21	0.21
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	1.68	0.00	0.00	0.28	0.28	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	0.00	0.00	0.00	1.03	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	1.16	0.58	0.00	0.87	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	1.20	0.30	0.00	0.90	0.00	0.60	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	1.66	0.00	0.00	0.00	0.00	0.00	0.55
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	0.71	0.00	0.00	0.00	0.35	0.35	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	0.38	0.00	0.00	0.77	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	1.13	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	0.82	0.00	0.82	0.82	0.00	0.00	0.82
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	0.45	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	1.44	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	1.49	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	0.00	0.37	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	0.86	0.86	0.43	0.43	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	0.00	0.86	0.00	0.86	0.86	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	1.33	0.33	0.00	0.33	0.00	0.33	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	1.21	0.60	0.00	0.60	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	0.71	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	0.34	0.00	0.34	0.34	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	0.54	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	0.00	0.00	0.67	0.00	0.00	0.67	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	1.48	0.74	0.37	0.37	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	3.49	0.00	0.00	1.16	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	0.00	0.00	1.06	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	1.20	0.80	0.40	0.40	0.40	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	0.73	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	1.53	0.77	0.00	0.00	0.00	0.00	0.77
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	0.49	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	0.94	0.94	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	0.50	0.50	0.00	0.00	0.00	0.50	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	0.45	0.00	0.00	0.45	0.45	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	1.72	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	0.00	0.45	0.00	0.45	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	1.17	0.00	0.00	0.39	0.39	0.39	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	0.66	0.66	0.00	0.66	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	0.52	0.52	0.00	0.00	0.00	0.52	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	0.88	0.00	0.00	0.44	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	1.12	0.00	0.00	1.12	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	1.32	0.88	0.00	0.88	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	0.39	0.00	0.77	0.77	0.39	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	1.01	0.00	0.51	2.03	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	1.44	0.00	0.00	0.96	0.00	0.48	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	0.80	0.00	0.00	0.00	0.40	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	1.22	1.22	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	2.08	0.00	0.00	0.69	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	1.90	0.38	0.00	1.52	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	2.07	0.52	0.52	0.52	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	0.60	0.00	0.00	0.00	1.21	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	1.27	0.63	0.32	0.63	0.63	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	0.53	0.00	0.00	0.53	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	1.15	0.00	0.00	0.00	0.00	1.15	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	2.57	0.00	0.00	1.03	0.51	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	3.54	0.00	0.00	0.71	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	0.57	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	2.50	1.25	0.83	0.83	0.42	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	0.78	0.78	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	0.84	0.42	0.42	1.25	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	1.39	0.46	0.00	0.46	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	0.67	0.00	0.67	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	1.07	0.53	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	1.21	0.40	0.00	0.40	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	0.92	0.00	0.92	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	0.89	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	0.57	0.57	0.00	0.57	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	1.53	0.77	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	3.83	1.09	0.00	1.09	0.00	0.55	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	0.89	0.00	0.45	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	2.08	0.52	0.00	0.00	0.00	0.78	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	1.99	0.00	0.66	1.99	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	6.38	0.23	0.23	1.60	0.23	0.23	0.00
Macrophage - monocyte derived, donor2	11313-117C8	9.36	2.20	0.73	1.28	0.37	0.73	0.00
Macrophage - monocyte derived, donor3	11389-118C3	7.21	1.05	0.79	1.84	0.39	0.39	0.00
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	14.87	2.12	0.53	2.66	1.59	1.59	0.00
Mallassez-derived cells, donor2	11929-125I3	24.88	4.60	1.11	14.10	1.43	1.74	0.48
Mallassez-derived cells, donor3	11930-125I4	14.32	1.67	0.97	6.53	1.25	0.14	0.42
Mammary Epithelial Cell, donor1	11273-116H4	22.32	2.49	0.10	7.47	1.30	0.10	0.10
Mammary Epithelial Cell, donor2	11350-117G9	24.03	2.90	1.45	11.87	0.87	0.29	0.00
Mammary Epithelial Cell, donor3	11422-118F9	7.73	1.50	1.25	2.99	0.75	1.00	0.50
Mast cell - stimulated, donor1	11487-119E2	17.63	1.36	2.03	4.75	0.68	0.00	0.68
Mast cell, donor1	11563-120D6	4.00	0.32	0.11	0.97	0.00	0.54	0.32
Mast cell, donor2	11565-120D8	2.38	0.00	0.30	0.00	0.00	0.00	0.00
Mast cell, donor3	11566-120D9	0.90	0.00	0.00	0.23	0.00	0.00	0.00
Mast cell, donor4	11567-120E1	0.53	0.00	0.00	0.18	0.18	0.00	0.00
Mast cell, expanded and stimulated, donor5	11940-126A5	2.88	0.11	0.33	0.44	0.11	0.33	0.11
Mast cell, expanded and stimulated, donor8	11942-126A7	9.34	0.58	0.58	0.58	0.58	0.58	0.00
Mast cell, expanded, donor5	11939-126A4	1.49	0.11	0.11	0.46	0.00	0.11	0.00
Mast cell, expanded, donor8	11941-126A6	0.67	0.00	0.33	0.17	0.17	0.17	0.00
Melanocyte - dark, donor1	11502-119F8	38.80	2.29	4.48	12.44	0.99	1.59	0.99
Melanocyte - dark, donor2	11582-120F7	55.37	7.27	8.31	26.99	1.38	1.38	2.08
Melanocyte - dark, donor3	11663-122F7	21.95	5.29	2.75	5.43	1.38	1.45	0.94
Melanocyte - light, donor1	11274-116H5	15.04	3.29	0.71	3.29	1.18	0.71	0.71
Melanocyte - light, donor2	11351-117H1	9.55	2.05	0.68	2.73	0.00	0.00	0.00
Melanocyte - light, donor3	11423-118G1	12.14	2.60	2.60	1.73	1.73	0.00	0.87
Melanocyte, donor1 (MC+1)	12641-134G4	32.80	4.27	1.77	10.20	1.77	1.04	0.21
Melanocyte, donor2 (MC+2)	12739-135I3	29.05	6.45	2.96	4.57	2.96	1.34	1.61
Melanocyte, donor3 (MC+3)	12837-137B2	25.45	5.62	2.41	5.89	3.21	1.87	0.00
Meningeal Cells, donor1	11493-119E8	34.98	9.06	2.36	13.52	3.10	2.85	0.87
Meningeal Cells, donor2	11573-120E7	42.69	13.64	10.12	17.61	4.84	1.32	1.32
Meningeal Cells, donor3	11654-122E7	36.84	8.97	4.65	7.74	2.12	3.67	1.14
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	79.84	16.54	7.70	10.55	2.57	7.70	2.85
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	101.44	19.93	13.18	26.16	2.11	9.06	3.72
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	23.65	7.88	1.31	13.14	1.31	5.26	1.31
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	17.01	9.16	5.23	3.92	0.00	1.31	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	53.82	10.05	5.74	12.92	1.44	5.02	2.15
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	64.17	11.22	7.62	24.99	0.64	3.81	1.27
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	54.79	11.56	5.53	32.67	0.50	1.01	0.50
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	39.34	9.89	8.13	14.06	1.10	4.18	1.54
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	29.22	2.92	4.38	13.15	1.46	2.19	0.73
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	26.60	6.96	3.27	6.34	1.02	2.66	1.23
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	131.03	39.20	9.83	51.11	2.77	10.67	3.74
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	25.65	7.06	5.58	12.64	1.49	3.35	0.74
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	101.97	13.95	9.21	29.47	1.58	5.53	2.11
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	44.51	5.04	5.04	15.43	0.30	2.67	1.48
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	16.35	14.01	2.34	7.01	0.00	2.34	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	60.20	17.29	9.61	16.65	1.28	4.48	4.48
Mesenchymal stem cells - adipose, donor0	11217-116B2	74.79	11.70	8.15	15.60	1.42	6.38	1.42
Mesenchymal stem cells - hepatic, donor0	11218-116B3	105.70	12.20	8.44	24.39	0.94	3.44	2.19
Mesenchymal stem cells - umbilical, donor0	11214-116A8	61.68	9.43	7.26	23.22	1.45	4.35	2.18
Mesothelial Cells, donor1	11247-116E5	34.74	9.28	5.04	8.49	6.10	3.45	2.65
Mesothelial Cells, donor2	12156-128G5	41.54	5.51	4.50	14.51	1.50	5.51	2.50
Mesothelial Cells, donor3	11402-118D7	37.00	9.18	6.21	6.07	3.25	4.84	1.88
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	10.80	2.70	0.00	2.70	0.00	0.00	1.35
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	6.65	0.25	0.49	2.71	0.25	0.25	0.49
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	8.24	2.06	1.47	1.18	0.29	0.29	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	24.20	0.00	0.00	3.46	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	5.27	0.62	0.31	1.55	0.31	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	3.11	1.04	0.83	1.45	0.62	0.62	0.21
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	16.21	2.32	0.00	2.32	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	3.75	1.00	0.00	2.50	0.00	0.25	0.25
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	5.12	1.86	0.00	3.72	0.93	0.47	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	5.28	1.02	0.00	1.42	0.61	0.61	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	5.54	1.19	0.40	1.58	0.40	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	8.55	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	0.88	1.77	0.00	2.65	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	6.46	0.00	1.52	1.90	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	19.74	1.32	0.00	1.32	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	4.03	0.85	0.00	0.64	0.21	0.00	0.21
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	3.68	0.92	0.00	0.92	0.00	0.92	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	4.17	0.30	0.89	2.98	0.30	0.00	0.30
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	3.35	1.68	0.00	0.00	0.00	3.35	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	5.02	2.01	0.50	3.51	0.50	0.25	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	4.04	1.19	1.19	0.48	0.48	0.48	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	21.01	3.87	2.21	4.98	0.00	3.32	0.55
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	7.37	1.84	0.23	3.45	0.23	0.23	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	6.73	1.68	0.63	2.94	0.84	0.42	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	8.56	1.83	0.41	3.67	0.41	1.02	0.20
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	5.15	1.29	0.43	3.65	0.86	1.29	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	8.89	1.78	0.00	2.45	0.67	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	30.96	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	9.20	1.97	1.10	5.26	0.44	0.66	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	10.14	3.04	1.01	3.04	0.51	0.51	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	18.23	3.31	0.00	1.66	0.00	1.66	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	10.87	3.81	1.63	5.98	0.82	0.82	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	7.35	2.06	0.59	5.00	0.59	0.88	0.29
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	27.26	0.00	1.09	8.72	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	11.53	2.40	0.96	6.25	0.48	0.00	0.48
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	12.41	2.80	0.40	4.00	1.60	1.20	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	23.31	2.74	0.00	4.11	0.00	1.37	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	13.52	3.00	0.50	5.51	0.50	0.50	1.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	8.15	0.00	0.00	18.35	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	17.08	6.13	1.31	10.07	1.31	0.44	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	16.55	0.00	2.21	3.31	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	19.85	2.56	1.28	6.40	1.92	1.92	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	21.07	3.72	1.98	11.16	1.24	0.25	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	14.61	5.57	1.39	6.26	0.70	0.70	0.70
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	15.47	8.84	0.00	6.63	0.00	2.21	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	19.49	3.08	1.03	7.52	1.37	1.37	0.34
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	17.50	2.19	1.75	6.13	0.44	0.44	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	24.50	2.49	1.07	6.04	0.71	0.71	0.36
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	19.64	2.81	0.84	10.66	1.40	1.68	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	17.87	2.49	1.25	9.56	0.42	0.83	1.25
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	18.65	1.75	1.17	4.66	0.58	0.00	0.58
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	19.00	2.11	0.90	9.35	1.51	0.90	0.60
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	21.70	2.92	0.83	8.77	0.42	0.42	0.42
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	28.88	0.00	0.00	21.66	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	24.94	4.62	0.92	4.62	0.92	0.92	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	27.32	3.98	1.14	10.81	0.57	1.14	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	18.10	2.07	1.52	6.63	1.11	0.55	0.14
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	13.22	3.11	0.26	8.81	0.78	1.30	1.04
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	15.01	2.14	1.29	8.58	0.43	0.86	0.43
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	15.24	1.91	0.64	7.62	0.00	0.64	0.64
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	16.28	4.80	1.33	9.07	0.27	1.07	0.27
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	14.37	2.69	0.90	5.69	0.60	0.90	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	12.29	1.55	0.71	4.38	0.71	1.13	0.14
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	15.61	3.50	0.96	9.56	1.27	1.59	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	19.02	3.54	1.33	10.17	0.88	1.55	0.22
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	19.72	3.79	1.14	7.58	1.14	1.14	0.76
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	18.18	3.41	0.85	6.53	1.70	0.57	0.28
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	15.49	2.95	1.72	9.59	1.72	0.49	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	14.99	1.30	0.00	3.26	1.30	1.96	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	15.88	2.35	2.35	5.88	1.18	0.29	0.29
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	11.24	4.32	1.15	5.77	0.58	0.58	0.86
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	11.95	1.24	0.41	2.47	2.06	1.65	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	16.08	2.08	0.60	6.25	2.38	0.89	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	3.77	3.77	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	3.56	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	3.94	0.33	0.00	1.64	0.00	0.00	0.33
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	5.26	0.00	2.10	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	5.54	0.00	0.20	1.58	0.40	0.40	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	10.24	1.86	0.00	0.93	0.00	0.93	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	4.13	0.38	0.38	2.63	1.13	0.38	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	5.33	1.33	0.80	1.07	0.80	0.27	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	4.07	0.11	0.11	1.92	0.11	0.11	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	4.42	0.74	0.00	0.74	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	2.20	0.37	0.73	2.56	0.37	0.37	0.37
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	6.22	1.56	0.00	3.11	1.56	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	4.28	0.53	0.53	2.14	0.00	0.53	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	3.86	0.00	0.00	7.73	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	5.05	0.00	0.00	3.03	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	5.48	0.42	0.42	2.53	0.00	0.42	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	1.36	1.36	0.00	5.45	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	5.72	0.00	0.64	1.91	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	4.86	0.81	0.81	1.62	0.00	0.81	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	3.02	0.00	0.00	3.02	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	11.42	0.00	0.00	11.42	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	22.84	0.00	0.00	22.84	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	4.75	0.00	0.00	23.76	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	0.00	12.55	12.55	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	50.84	7.32	4.09	26.71	2.37	3.02	1.08
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	41.29	5.75	6.27	13.07	1.57	2.61	1.05
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	57.40	6.67	2.67	12.68	1.33	6.01	0.67
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	33.81	15.44	1.67	8.35	1.67	0.83	0.83
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	24.53	6.46	1.52	5.32	1.90	1.33	0.19
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	55.85	11.17	4.79	25.53	1.60	6.38	1.60
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	40.12	10.20	3.40	9.52	2.04	4.76	0.68
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	84.53	5.51	3.68	22.05	1.84	1.84	1.84
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	59.85	20.93	2.93	13.39	2.51	6.70	2.09
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	37.89	14.41	4.65	6.74	2.32	2.09	0.46
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	43.51	21.35	4.32	12.97	3.24	4.32	2.16
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	59.08	18.71	10.72	18.29	2.94	6.94	1.68
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	200.42	44.54	22.27	44.54	0.00	44.54	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	36.23	20.85	3.97	12.41	0.99	4.96	0.50
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	41.41	13.26	3.25	8.12	3.25	3.25	0.81
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	50.55	25.84	4.53	11.56	4.76	2.95	0.91
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	48.99	21.88	10.12	6.37	4.74	6.21	2.29
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	58.69	19.68	11.48	12.76	2.19	6.74	2.55
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	68.96	22.28	14.32	11.14	2.65	5.83	2.12
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	51.03	23.41	6.00	6.60	2.40	9.00	1.80
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	36.10	7.88	3.94	7.22	0.66	3.61	1.31
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	41.47	32.04	11.06	7.81	2.28	5.20	1.46
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	61.73	20.99	12.70	13.93	1.41	8.29	2.65
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	63.99	26.02	7.74	12.66	2.11	8.44	4.22
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	54.71	18.39	5.06	11.95	5.06	3.22	1.84
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	81.62	40.49	15.10	16.07	3.21	13.50	4.18
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	34.14	10.69	3.10	5.52	1.72	3.79	0.69
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	113.78	10.11	10.11	17.70	0.00	7.59	7.59
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	61.04	20.50	13.81	19.16	1.56	6.91	3.56
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	60.55	16.94	5.93	8.47	2.12	3.81	1.27
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	39.88	11.39	2.37	6.65	2.85	3.32	0.71
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	101.73	43.35	22.75	18.89	1.29	15.45	3.43
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	234.72	90.28	27.08	45.14	9.03	0.00	9.03
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	59.65	29.32	12.33	13.66	1.67	7.33	5.66
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	59.96	17.13	11.72	26.60	0.45	5.86	0.45
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	68.65	16.27	7.54	12.70	1.98	6.75	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	56.65	18.57	7.43	14.86	2.79	9.29	1.86
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	51.84	20.43	9.46	10.97	1.51	5.30	1.51
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	53.45	32.91	13.04	13.69	2.61	5.54	2.28
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	44.89	26.15	10.46	9.15	2.18	7.84	2.61
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	67.84	20.81	11.76	22.61	1.36	7.69	2.26
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	64.38	34.39	7.06	14.99	5.29	3.53	3.53
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	78.45	35.24	11.30	19.28	3.99	8.64	3.32
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	79.37	31.25	22.82	21.33	0.99	13.89	2.98
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	43.64	27.18	11.10	16.84	1.53	3.45	1.91
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	84.08	27.52	15.73	15.42	5.44	7.26	3.02
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	60.78	20.56	11.27	24.53	1.33	5.97	2.21
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	65.73	18.97	17.62	17.62	1.36	8.13	0.68
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	158.40	40.88	10.22	35.77	5.11	5.11	5.11
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	90.84	41.46	16.46	20.12	0.00	12.80	3.05
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	41.23	23.92	10.07	10.70	3.15	5.35	2.52
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	47.52	28.15	9.38	9.38	2.42	5.75	2.72
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	71.20	26.11	9.49	15.82	1.58	6.33	1.58
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	55.55	7.94	3.40	15.87	5.67	1.13	1.13
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	111.27	30.35	0.00	30.35	5.06	15.17	5.06
Myoblast, donor1	11241-116D8	41.74	11.80	3.98	10.81	3.23	0.99	0.87
Myoblast, donor2	11322-117D8	38.36	11.51	4.79	8.82	3.64	4.03	0.58
Myoblast, donor3	11398-118D3	53.98	8.74	7.23	14.13	2.86	3.03	1.85
NK T cell leukemia cell line:KHYG-1	10777-110G3	8.76	0.44	1.46	2.77	0.73	0.73	0.15
Natural Killer Cells, donor1	11230-116C6	4.92	0.00	0.62	1.23	0.00	0.00	0.00
Natural Killer Cells, donor2	11311-117C6	3.62	0.90	0.00	0.60	0.00	0.00	0.00
Natural Killer Cells, donor3	11387-118C1	3.87	0.92	0.92	0.55	0.18	0.74	0.37
Neural stem cells, donor1	11275-116H6	45.37	13.79	5.81	10.89	6.17	4.72	0.73
Neural stem cells, donor2	11352-117H2	28.88	5.78	5.78	11.55	0.00	3.85	0.00
Neurons, donor1	11494-119E9	25.03	9.10	2.28	7.97	1.14	1.14	2.28
Neurons, donor2	11574-120E8	16.29	5.28	2.20	3.52	2.86	0.88	1.10
Neurons, donor3	11655-122E8	24.66	6.58	3.29	7.40	2.47	2.47	0.82
Neutrophils, donor1	11233-116C9	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Neutrophils, donor2	11314-117C9	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	59.13	30.75	8.43	6.17	7.48	2.14	2.97
Nucleus Pulposus Cell, donor2	11409-118E5	41.35	18.56	10.09	8.14	3.91	1.63	0.33
Nucleus Pulposus Cell, donor3	11462-119B4	54.35	32.89	5.82	18.05	6.22	1.20	1.20
Olfactory epithelial cells, donor1	11933-125I7	49.83	8.95	4.68	9.50	1.79	2.62	1.38
Olfactory epithelial cells, donor2	11934-125I8	58.04	8.68	3.91	14.62	2.03	2.61	1.30
Olfactory epithelial cells, donor3	11935-125I9	53.91	8.85	4.65	12.37	2.61	2.27	1.02
Olfactory epithelial cells, donor4	11936-126A1	72.95	12.66	7.50	13.93	2.34	5.75	2.14
Oligodendrocyte - precursors, donor1	11496-119F2	37.91	12.64	4.21	16.85	3.01	4.21	1.81
Osteoblast - differentiated, donor1	11276-116H7	66.57	19.36	8.72	23.82	1.49	5.96	2.13
Osteoblast - differentiated, donor2	11353-117H3	50.30	13.72	10.29	14.86	3.43	9.14	0.00
Osteoblast - differentiated, donor3	11425-118G3	41.59	9.93	4.34	10.55	4.34	0.00	0.62
Osteoblast, donor1	11277-116H8	33.03	10.16	5.08	6.45	2.35	1.37	1.56
Osteoblast, donor2	11354-117H4	94.11	25.99	9.83	33.71	2.81	6.32	3.51
Osteoblast, donor3	11426-118G4	77.13	22.39	15.64	16.17	1.96	6.40	3.02
Pancreatic stromal cells, donor1	11249-116E7	99.99	17.77	10.28	19.88	3.03	4.80	2.02
Pericytes, donor1	11491-119E6	14.91	5.01	1.56	4.34	0.78	2.45	0.67
Pericytes, donor2	11571-120E5	15.39	9.05	4.30	3.85	0.45	2.04	1.36
Pericytes, donor3	11652-122E5	62.05	18.72	11.60	19.73	3.05	4.27	2.03
Perineurial Cells, donor1	11499-119F5	92.90	17.52	18.31	23.06	2.94	5.54	3.96
Perineurial Cells, donor2	11579-120F4	83.91	11.23	7.82	26.59	1.84	5.15	2.21
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	2.87	0.00	0.00	1.27	0.00	0.32	0.00
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	4.16	0.49	0.00	0.00	0.49	0.00	0.00
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	3.49	1.16	0.52	0.65	0.39	0.39	0.00
Placental Epithelial Cells, donor1	11278-116H9	6.70	1.43	0.24	4.07	1.20	0.24	0.00
Placental Epithelial Cells, donor2	11355-117H5	25.50	4.44	0.00	13.31	0.00	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	31.61	3.93	3.14	7.07	1.96	0.79	0.59
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	32.59	15.19	1.90	15.19	1.90	3.16	0.95
Preadipocyte - breast, donor1	11467-119B9	48.02	13.51	2.81	16.13	2.25	0.94	1.13
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	54.82	5.87	3.26	16.71	2.09	1.17	0.91
Preadipocyte - breast, donor2	11328-117E5	47.51	15.54	6.75	15.99	4.73	0.90	2.03
Preadipocyte - omental, donor1	11468-119C1	70.65	14.28	8.95	24.19	3.41	5.43	2.45
Preadipocyte - omental, donor2	11329-117E6	47.14	12.22	4.80	14.84	2.62	2.18	2.18
Preadipocyte - omental, donor3	11403-118D8	78.07	18.91	12.89	25.50	2.58	5.59	2.72
Preadipocyte - perirenal, donor1	11469-119C2	28.54	12.80	2.95	18.70	0.98	0.98	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	41.15	6.76	4.30	9.83	0.92	1.84	1.23
Preadipocyte - subcutaneous, donor2	11356-117H6	90.66	13.28	8.68	18.24	3.36	5.14	2.12
Preadipocyte - subcutaneous, donor3	11428-118G6	130.61	19.92	18.22	22.14	1.87	6.47	3.58
Preadipocyte - visceral, donor1	11280-116I2	97.25	18.35	9.97	21.98	4.01	3.35	1.49
Preadipocyte - visceral, donor2	11357-117H7	76.85	16.11	5.52	9.66	3.22	3.22	0.92
Preadipocyte - visceral, donor3	11429-118G7	79.52	15.05	6.69	22.26	2.61	4.70	1.25
Prostate Epithelial Cells (polarized), donor1	11253-116F2	28.66	6.03	2.72	10.71	2.87	0.75	0.91
Prostate Epithelial Cells, donor2	11331-117E8	18.42	2.98	1.49	4.33	1.35	1.49	0.41
Prostate Epithelial Cells, donor3	11404-118D9	23.52	4.53	1.90	5.21	3.06	0.24	0.43
Prostate Stromal Cells, donor1	11254-116F3	107.75	15.49	11.50	23.81	2.51	6.95	3.76
Prostate Stromal Cells, donor2	11332-117E9	89.83	20.08	14.88	19.72	2.15	8.43	2.69
Prostate Stromal Cells, donor3	11405-118E1	76.75	20.33	10.95	13.66	5.21	4.48	3.75
Renal Cortical Epithelial Cells, donor1	11516-119H4	25.18	3.28	4.01	13.14	3.65	1.82	0.36
Renal Cortical Epithelial Cells, donor2	11596-120H3	36.67	5.61	2.91	11.09	2.98	2.84	1.46
Renal Epithelial Cells, donor1	11517-119H5	11.16	3.55	1.52	3.55	1.52	0.51	0.00
Renal Epithelial Cells, donor2	11597-120H4	16.36	4.27	2.13	9.96	0.00	1.42	0.71
Renal Epithelial Cells, donor3	11678-122H4	44.04	7.41	2.65	11.22	3.92	1.69	1.59
Renal Glomerular Endothelial Cells, donor1	11514-119H2	23.15	8.85	3.40	8.17	0.68	1.36	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	32.75	6.87	2.70	15.09	1.75	2.02	0.81
Renal Glomerular Endothelial Cells, donor3	11675-122H1	35.52	5.77	5.99	10.66	1.33	1.55	0.44
Renal Glomerular Endothelial Cells, donor4	11783-124B1	13.97	1.33	1.33	5.32	0.67	1.33	0.00
Renal Mesangial Cells, donor1	11518-119H6	19.15	4.62	3.08	5.50	0.44	1.98	0.00
Renal Mesangial Cells, donor2	11598-120H5	22.57	10.03	1.88	6.27	2.51	2.51	1.25
Renal Mesangial Cells, donor3	11679-122H5	12.48	2.77	1.39	1.66	1.11	1.11	1.11
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	42.68	6.17	3.49	19.06	2.42	3.49	1.34
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	29.94	4.22	2.53	11.39	1.27	3.37	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	35.10	5.59	2.51	6.56	2.12	1.54	0.39
Retinal Pigment Epithelial Cells, donor0	11215-116A9	43.30	9.85	8.56	10.37	4.67	3.37	3.11
Retinal Pigment Epithelial Cells, donor1	11528-119I7	37.52	6.25	5.97	11.94	1.42	4.83	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	14.41	6.17	0.00	5.15	1.03	3.09	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	38.64	9.28	6.02	12.04	4.01	3.26	1.25
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	31.14	3.07	2.54	10.16	2.14	0.53	0.67
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	42.88	7.15	2.68	9.83	1.79	0.89	0.89
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	15.41	1.65	0.55	8.26	0.55	0.55	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	22.62	1.16	0.00	14.50	0.00	2.90	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	21.32	3.38	1.82	10.66	1.82	1.82	0.65
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	23.04	3.28	3.48	6.16	2.09	2.09	1.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	30.23	5.47	4.13	9.26	4.57	3.68	1.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	39.94	5.09	4.34	9.55	1.74	2.11	0.87
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	28.67	4.66	3.61	6.06	2.21	2.45	0.82
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	25.19	8.09	4.39	6.24	1.39	1.62	0.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	23.96	5.48	2.74	14.79	1.51	1.37	0.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	27.99	4.84	3.03	7.41	1.36	1.82	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	27.06	4.66	2.69	6.45	1.61	2.87	0.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	24.67	3.73	4.02	13.63	1.43	1.86	0.72
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	24.79	3.76	3.11	5.58	2.25	2.58	0.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	27.66	5.97	3.10	6.20	1.99	1.11	0.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	24.28	5.35	3.44	13.38	1.53	1.15	0.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	23.94	4.75	3.35	4.47	2.33	1.68	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	29.50	6.01	3.57	9.21	1.88	2.63	1.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	24.02	5.04	2.52	11.81	2.79	1.59	0.80
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	27.55	6.23	3.80	5.94	2.14	2.73	1.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	32.27	7.26	5.16	7.26	1.72	2.86	0.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	22.00	4.70	3.20	12.82	1.28	1.39	0.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	27.19	5.05	2.24	4.48	1.68	1.96	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	21.70	5.98	2.39	5.47	2.39	1.37	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	23.34	4.92	2.55	13.67	2.01	1.64	0.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	28.45	5.15	4.54	7.11	1.47	2.70	0.74
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	30.22	7.39	3.76	8.33	2.28	3.22	1.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	22.64	4.01	2.83	19.11	1.18	1.65	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	26.19	3.57	2.18	6.75	2.18	2.58	0.79
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	27.36	6.08	3.51	7.48	3.27	0.94	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	20.74	4.77	2.49	13.06	2.07	1.24	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	20.35	3.32	1.99	4.87	2.88	1.11	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	22.56	6.27	2.72	8.77	2.30	2.30	0.63
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	23.82	3.63	3.10	13.46	1.88	1.08	0.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	26.74	5.28	4.77	8.17	1.53	2.38	1.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	26.61	4.43	3.86	6.36	2.31	2.31	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	22.52	4.99	2.41	15.30	2.58	2.06	1.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	25.92	5.76	2.74	6.72	3.02	2.19	1.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	26.92	5.42	3.12	7.22	2.63	2.46	1.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	22.33	3.75	2.90	11.08	2.56	1.87	1.02
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	26.04	6.21	3.85	7.10	2.22	2.96	0.74
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	25.06	4.80	3.73	7.46	1.60	0.53	0.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	24.47	3.73	2.49	11.48	2.35	1.52	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	22.14	5.24	2.38	3.81	1.90	1.43	0.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	24.18	5.64	2.42	5.44	2.62	1.41	0.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	18.08	3.01	1.60	8.19	0.94	1.22	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	29.70	5.94	2.45	8.04	1.75	2.10	0.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	24.78	6.04	1.51	7.56	2.12	0.30	0.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	19.70	2.69	1.47	7.34	1.22	0.86	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	37.84	5.39	3.93	10.04	2.91	2.04	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	24.95	7.91	5.48	12.78	1.83	1.22	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	14.77	3.01	1.51	4.52	0.90	0.90	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	37.55	3.85	4.07	11.08	2.26	2.71	1.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	32.65	5.69	3.89	6.29	2.70	1.20	1.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	29.64	4.72	2.01	11.69	2.13	0.35	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	35.22	3.63	3.84	8.11	1.49	1.07	0.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	40.87	6.61	4.21	10.22	3.61	2.40	0.60
Schwann Cells, donor1	11498-119F4	24.64	6.77	2.63	6.39	1.69	3.39	0.75
Schwann Cells, donor2	11578-120F3	34.02	6.80	0.00	6.80	3.40	3.40	3.40
Schwann Cells, donor3	11659-122F3	40.97	9.86	4.82	16.87	1.97	3.94	1.75
Sebocyte, donor1	11220-116B5	27.94	2.74	2.19	6.03	2.74	0.00	0.55
Sebocyte, donor2	11301-117B5	12.87	1.84	0.46	1.38	1.38	0.00	0.92
Sebocyte, donor3	11378-118B1	35.04	10.51	3.92	6.39	1.44	1.44	1.03
Sertoli Cells, donor1	11255-116F4	152.41	23.19	21.54	26.51	9.94	16.57	4.97
Sertoli Cells, donor2	11333-117F1	56.49	25.42	5.65	14.12	2.82	5.65	0.00
Skeletal Muscle Cells, donor1	11281-116I3	63.78	24.19	10.21	7.48	5.98	4.84	4.75
Skeletal Muscle Cells, donor2	11358-117H8	37.59	10.12	7.95	6.51	0.72	2.17	0.72
Skeletal Muscle Cells, donor3	11430-118G8	55.18	17.56	7.52	7.52	2.51	5.02	2.51
Skeletal Muscle Cells, donor4	11451-119A2	65.35	20.74	8.17	13.51	3.30	4.40	3.14
Skeletal Muscle Cells, donor5	11455-119A6	61.54	22.30	6.39	11.15	2.53	7.13	1.78
Skeletal Muscle Cells, donor6	11459-119B1	60.48	17.08	6.93	14.31	1.85	5.85	1.54
Skeletal Muscle Satellite Cells, donor1	11240-116D7	127.39	27.47	13.23	26.08	3.53	9.95	6.68
Skeletal Muscle Satellite Cells, donor2	11321-117D7	91.32	22.26	17.98	16.98	3.42	8.56	3.28
Skeletal Muscle Satellite Cells, donor3	11397-118D2	75.00	26.19	15.18	12.50	5.56	6.35	3.37
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	95.88	34.54	11.88	15.50	2.78	11.46	4.21
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	25.33	14.48	7.24	5.07	3.62	0.72	1.45
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	29.58	8.81	4.54	5.64	1.10	1.79	1.38
Skin - palm, donor1	10286-104F7	5.37	0.00	0.00	8.06	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	11.82	3.60	0.43	6.49	1.15	1.01	0.29
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	9.81	3.27	0.00	20.45	1.64	0.00	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	11.81	1.69	0.65	6.23	0.78	0.26	0.00
Small Airway Epithelial Cells, donor1	11256-116F5	31.14	2.64	1.53	8.62	1.53	1.67	0.42
Small Airway Epithelial Cells, donor2	11334-117F2	27.15	4.08	1.83	9.00	2.39	1.41	0.98
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	39.54	1.27	1.06	10.57	1.27	2.75	0.85
Small Airway Epithelial Cells, donor3	11406-118E2	28.93	4.05	3.15	9.07	2.77	1.27	0.52
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	21.91	25.30	6.79	9.26	4.01	2.16	1.85
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	195.87	14.01	15.79	141.85	3.33	8.45	1.33
Smooth Muscle Cells - Aortic, donor0	11210-116A4	68.78	18.81	9.99	13.52	4.70	4.11	2.35
Smooth Muscle Cells - Aortic, donor1	11283-116I5	50.61	13.48	5.97	8.84	3.09	2.43	1.77
Smooth Muscle Cells - Aortic, donor2	11360-117I1	32.68	8.27	5.51	12.21	3.15	2.76	1.58
Smooth Muscle Cells - Aortic, donor3	11432-118H1	72.62	22.40	10.82	27.81	1.55	2.32	0.77
Smooth Muscle Cells - Bladder, donor1	11519-119H7	76.06	9.01	7.01	8.01	2.00	3.00	1.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	58.95	11.31	6.92	11.71	3.33	3.06	1.06
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	124.79	31.47	20.61	37.24	3.99	7.76	2.88
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	57.74	13.83	7.55	21.89	2.82	5.25	1.92
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	67.40	9.77	10.09	12.37	3.91	5.86	3.58
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	85.35	19.49	15.65	20.67	1.77	5.91	6.79
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	92.96	18.93	25.63	22.49	2.70	7.83	5.98
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	38.55	9.44	4.23	9.44	0.98	3.58	1.79
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	63.93	17.66	9.13	17.05	3.35	1.52	3.04
Smooth Muscle Cells - Carotid, donor1	11285-116I7	80.06	23.24	8.08	10.36	5.05	1.77	1.26
Smooth Muscle Cells - Carotid, donor2	11362-117I3	6.12	0.00	0.00	0.00	6.12	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	30.99	6.68	1.91	4.77	1.43	1.91	0.48
Smooth Muscle Cells - Colonic, donor1	11239-116D6	86.71	14.89	7.96	15.48	3.54	4.72	3.10
Smooth Muscle Cells - Colonic, donor2	11320-117D6	80.71	21.74	12.27	26.04	2.15	6.67	3.23
Smooth Muscle Cells - Colonic, donor3	11396-118D1	88.90	21.20	15.74	20.05	2.73	5.04	3.57
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	43.77	9.28	3.56	15.00	2.63	3.87	1.24
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	18.32	6.47	1.08	6.47	1.08	2.16	1.08
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	42.44	12.85	5.08	10.76	1.79	2.99	2.09
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	26.63	17.41	4.10	7.17	2.73	0.34	2.39
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	81.91	40.21	12.01	13.59	6.44	4.00	4.16
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	67.13	20.63	9.06	16.40	3.52	6.14	3.42
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	131.53	28.67	24.12	38.23	4.32	7.96	3.87
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	34.42	14.49	1.81	21.13	2.42	4.23	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	70.21	14.04	11.13	15.90	2.38	9.01	1.59
Smooth Muscle Cells - Prostate, donor1	11257-116F6	82.29	21.31	6.79	31.69	3.20	4.13	1.46
Smooth Muscle Cells - Prostate, donor2	11335-117F3	114.58	29.18	20.66	36.44	2.75	8.77	3.63
Smooth Muscle Cells - Prostate, donor3	11465-119B7	65.95	13.44	4.31	17.50	1.01	2.03	1.27
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	67.09	17.64	5.88	15.68	5.58	2.71	1.36
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	45.76	21.75	7.50	12.00	6.75	2.25	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	27.14	6.46	5.17	9.05	5.17	2.58	1.29
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	51.62	18.14	6.05	12.56	2.79	3.26	1.86
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	54.02	10.10	5.55	12.62	4.04	4.04	1.01
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	69.57	14.10	5.64	23.50	2.51	3.76	1.57
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	30.09	19.47	4.13	11.80	2.65	2.06	1.18
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	85.22	27.32	11.83	21.58	5.25	3.58	2.25
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	84.09	26.16	8.88	13.55	6.54	3.74	0.47
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	38.43	10.36	3.60	11.66	1.44	1.58	1.01
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	37.99	8.67	4.84	5.86	1.78	1.27	1.53
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	28.96	7.52	3.95	6.77	1.88	3.38	1.88
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	100.48	16.35	12.72	23.06	2.52	7.27	2.66
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	143.53	19.10	20.70	36.62	2.77	9.30	4.61
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	22.38	4.76	3.81	6.67	0.95	1.43	0.48
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	30.09	12.72	2.69	10.03	3.18	3.18	1.47
Smooth Muscle Cells - Uterine, donor1	11258-116F7	95.67	23.20	9.50	43.31	1.33	9.28	2.65
Smooth Muscle Cells - Uterine, donor3	11466-119B8	43.30	6.14	3.22	7.61	1.17	4.39	0.59
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	74.44	18.46	5.83	31.29	2.72	6.03	2.33
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	52.10	15.34	4.50	34.38	1.85	5.55	0.53
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	47.61	6.32	4.09	42.40	1.12	2.60	0.74
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	59.29	18.69	5.39	40.25	4.67	3.23	2.87
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	30.38	11.64	1.99	17.89	1.99	1.70	1.42
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	44.90	11.82	3.94	29.54	2.76	3.15	1.18
Smooth muscle cells - airway, control, donor1	11966-126D4	56.89	17.01	3.05	23.62	4.06	3.30	1.02
Smooth muscle cells - airway, control, donor2	11967-126D5	56.30	24.76	4.79	23.16	3.19	3.19	3.19
Smooth muscle cells - airway, control, donor3	11968-126D6	50.58	25.92	6.69	22.99	3.34	3.76	0.84
Smooth muscle cells - airway, control, donor4	11969-126D7	62.80	15.58	3.67	27.04	1.38	3.67	1.83
Synoviocyte, donor1	11291-117A4	61.27	15.82	4.04	23.40	1.68	3.53	1.35
Synoviocyte, donor2	11368-117I9	75.77	18.77	8.88	11.90	5.20	2.51	1.01
Synoviocyte, donor3	11440-118H9	52.28	14.52	5.81	16.31	1.56	2.23	1.34
Trabecular Meshwork Cells, donor1	11532-120A2	35.38	15.72	2.86	11.08	0.71	2.14	2.14
Trabecular Meshwork Cells, donor2	11612-122A1	15.86	9.91	5.95	9.91	0.00	5.95	3.96
Trabecular Meshwork Cells, donor3	11693-123A1	35.43	6.48	4.40	6.02	1.62	2.32	1.62
Tracheal Epithelial Cells, donor1	11292-117A5	14.12	2.22	0.93	3.30	1.22	0.65	0.14
Tracheal Epithelial Cells, donor2	11369-118A1	10.05	1.93	0.00	1.16	1.16	0.39	0.39
Tracheal Epithelial Cells, donor3	11441-118I1	13.17	0.57	0.57	3.44	0.57	0.57	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	31.00	3.69	1.48	10.83	2.21	0.62	0.49
Urethra, donor2	10319-105A4	30.57	5.40	1.80	10.79	1.80	0.00	0.00
Urothelial Cells, donor1	11520-119H8	16.74	2.13	1.86	5.31	2.13	0.53	0.53
Urothelial Cells, donor2	11600-120H7	9.21	2.80	1.20	3.20	2.40	0.00	0.80
Urothelial Cells, donor3	11681-122H7	7.79	2.52	0.00	2.98	1.83	0.23	0.23
Urothelial cells, donor0	11216-116B1	28.31	5.35	1.34	8.02	3.12	2.01	1.56
Whole blood (ribopure), donor090309, donation1	12179-129A1	6.23	0.00	0.00	0.00	0.00	0.89	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	4.29	0.00	0.00	0.00	1.43	1.43	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	0.00	0.00	0.68	2.05	0.00	0.00	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	1.72	0.34	0.00	1.72	0.34	0.00	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	0.00	0.00	0.00	0.58	0.58	0.00	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	1.04	0.00	0.00	1.04	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	1.84	0.00	0.00	1.84	0.92	0.92	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	1.83	0.00	0.91	0.91	0.00	0.00	1.83
Wilms' tumor cell line:G-401	10809-111A8	15.91	7.28	3.95	3.95	0.74	3.08	1.11
Wilms' tumor cell line:HFWT	10597-108E3	32.56	5.28	3.52	9.68	5.28	2.64	0.88
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	50.28	6.42	2.51	10.89	5.31	0.28	0.28
achilles tendon, donor2	10292-104G4	18.60	2.07	0.00	4.13	2.07	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	5.86	4.08	2.04	1.78	1.53	2.55	0.76
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	13.70	4.18	3.48	2.09	1.86	2.32	0.93
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	18.40	14.36	5.22	4.51	4.51	7.12	2.61
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	9.80	12.79	2.72	2.72	5.99	5.17	1.09
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	10.68	1.97	2.81	3.37	1.97	0.84	0.00
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	12.27	2.33	0.85	2.33	2.75	2.54	0.00
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	20.42	1.36	2.99	7.62	1.09	1.09	0.54
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	19.83	4.41	4.41	5.73	4.41	1.32	0.44
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	22.87	3.27	1.23	6.53	2.45	2.86	1.63
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	13.98	5.05	3.11	3.49	2.33	3.11	0.39
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	15.60	11.70	11.70	3.90	3.90	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	16.03	4.42	3.02	5.81	1.63	2.32	0.46
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	6.73	2.59	2.07	2.59	1.04	3.88	0.52
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	14.03	2.34	1.46	4.97	0.88	2.05	0.29
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	28.35	0.00	1.86	8.37	0.93	0.46	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	12.75	7.81	2.88	5.76	1.65	3.29	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	9.82	3.07	0.61	1.84	1.23	4.30	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	13.23	3.84	0.85	0.85	1.71	1.71	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	8.19	1.52	1.21	2.12	1.52	1.82	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	9.87	3.37	0.72	2.41	1.68	4.09	0.48
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	6.24	0.89	0.67	1.78	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	3.67	1.00	0.33	2.00	1.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	33.45	5.57	3.72	7.43	0.00	0.00	1.86
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	10.92	3.39	1.88	3.77	0.38	0.00	0.75
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	16.57	1.74	4.36	6.54	0.87	1.74	0.44
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	13.12	0.00	0.00	11.25	1.87	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	44.04	2.59	2.35	19.31	3.06	1.41	0.47
adipose tissue, adult, pool1	10010-101C1	28.70	2.17	0.78	8.38	1.71	0.78	0.00
adipose, donor1	10184-103D4	61.57	8.21	9.97	14.66	1.76	1.17	1.17
adipose, donor2	10185-103D5	34.47	19.06	14.19	10.14	6.08	1.22	1.62
adipose, donor3	10186-103D6	35.40	20.42	6.53	7.35	4.90	3.00	1.91
adipose, donor4	10187-103D7	28.60	15.60	9.53	4.33	7.80	3.47	1.73
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	10.73	14.68	2.68	1.89	4.73	3.95	1.42
adrenal gland, adult, pool1	10081-102A9	7.28	7.28	0.00	3.64	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	1.47	0.00	0.13	0.40	0.00	0.13	0.00
alveolar cell carcinoma cell line:SW 1573	10708-109H6	33.23	8.22	0.71	8.58	6.07	1.07	0.36
amniotic membrane cells, donor1	12235-129G3	21.10	1.62	1.39	9.51	1.16	0.00	0.23
amniotic membrane cells, donor2	12236-129G4	33.81	11.50	2.03	6.09	1.69	0.68	0.00
amniotic membrane cells, donor3	12237-129G5	15.02	2.65	0.00	4.42	0.88	0.00	0.00
amygdala - adult, donor10196	10167-103B5	7.11	18.97	4.74	5.93	2.37	4.74	1.19
amygdala, adult, donor10252	10151-102I7	6.49	5.68	1.82	3.04	4.06	1.42	0.41
amygdala, newborn, donor10223	10360-105E9	5.49	4.20	0.65	6.13	0.32	0.97	0.00
anaplastic carcinoma cell line:8305C	10428-106D5	160.31	48.00	25.85	29.41	6.75	10.57	5.86
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	21.18	7.50	3.09	8.60	3.09	2.21	0.88
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	23.72	17.04	12.36	1.67	2.34	13.36	6.01
aorta, adult, pool1	10052-101G7	19.81	3.14	1.57	4.31	2.16	0.20	0.20
appendix, adult	10189-103D9	18.63	5.05	1.16	8.93	1.55	1.55	0.78
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	31.64	3.10	2.06	11.35	5.85	1.72	0.69
artery, adult	10190-103E1	13.59	4.08	1.36	2.72	0.00	1.36	0.00
astrocytoma cell line:TM-31	10425-106D2	74.61	18.11	10.72	20.43	4.06	5.07	3.33
b cell line:RPMI1788	10427-106D4	16.80	5.65	3.27	3.42	2.53	5.20	0.74
basal cell carcinoma cell line:TE 354.T	10702-109G9	68.53	10.82	8.05	33.85	2.50	1.39	1.11
bile duct carcinoma cell line:HuCCT1	10432-106D9	66.29	14.98	4.86	23.91	5.56	1.89	0.79
bile duct carcinoma cell line:TFK-1	10496-107C1	19.92	2.18	0.67	6.53	1.17	1.34	0.33
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	10.63	0.56	1.12	2.24	0.00	0.56	0.56
bladder, adult, pool1	10011-101C2	24.88	2.17	1.30	4.78	1.74	1.09	0.76
blood, adult, pool1	10053-101G8	2.21	0.00	0.00	0.00	2.21	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	60.80	9.42	6.85	38.54	5.14	3.43	0.00
bone marrow, adult	10192-103E3	33.74	2.02	1.35	11.47	1.35	2.02	0.00
brain, adult, donor1	10084-102B3	12.30	5.13	2.05	4.10	3.08	1.03	0.00
brain, adult, pool1	10012-101C3	6.01	3.23	1.00	3.12	0.89	1.22	0.33
brain, fetal, pool1	10085-102B4	10.69	5.34	0.00	0.00	0.00	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	18.17	1.65	0.33	6.61	0.99	0.66	0.33
breast carcinoma cell line:MDA-MB-453	10419-106C5	12.36	3.12	0.37	3.37	1.00	0.50	0.37
breast, adult, donor1	10080-102A8	40.41	4.42	2.53	12.00	2.53	0.00	0.63
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	63.01	9.91	3.43	10.42	3.30	3.43	0.51
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	22.57	5.57	0.93	7.42	3.71	0.93	0.62
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	73.67	10.36	3.45	14.73	6.45	4.60	0.23
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	8.96	0.73	0.48	0.48	0.00	0.24	0.00
carcinoid cell line:NCI-H1770	10703-109H1	21.63	28.68	6.58	6.58	13.63	6.58	2.82
carcinoid cell line:NCI-H727	10735-110B6	61.47	9.52	3.17	24.83	4.16	2.30	0.44
carcinoid cell line:SK-PN-DW	10719-109I8	0.00	0.00	0.00	0.00	0.63	0.32	0.32
carcinosarcoma cell line:JHUCS-1	10642-109A3	96.89	33.27	17.57	16.77	12.51	8.52	4.53
caudate nucleus - adult, donor10196	10177-103C6	10.36	19.57	1.15	11.51	6.91	8.06	2.30
caudate nucleus, adult, donor10252	10164-103B2	7.53	21.42	2.01	2.68	11.88	4.02	3.51
caudate nucleus, adult, donor10258	10379-105H1	9.93	29.04	1.53	10.70	9.93	9.93	6.11
caudate nucleus, newborn, donor10223	10354-105E3	9.16	7.32	0.73	7.32	4.03	2.93	0.73
cerebellum - adult, donor10196	10173-103C2	20.39	2.91	2.91	17.48	0.00	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	8.97	2.35	1.92	3.84	1.28	0.43	1.07
cerebellum, adult, pool1	10083-102B2	10.35	1.03	1.72	4.83	0.69	1.03	0.69
cerebellum, newborn, donor10223	10357-105E6	16.61	0.83	0.00	11.62	0.83	0.00	0.00
cerebral meninges, adult	10188-103D8	11.85	4.29	1.76	3.28	3.28	1.76	0.25
cerebrospinal fluid, donor2	10294-104G6	4.39	5.12	0.00	1.46	1.46	0.00	0.00
cervical cancer cell line:D98-AH2	10552-107I3	51.62	18.40	3.02	15.53	5.46	0.86	0.29
cervical cancer cell line:ME-180	10553-107I4	70.76	10.27	3.81	21.87	2.65	2.49	0.66
cervix, adult, pool1	10013-101C4	35.49	7.14	2.62	6.40	3.25	3.67	1.15
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	0.00	0.14	0.00	0.28	0.00	0.00	0.00
chondrosarcoma cell line:SW 1353	10700-109G7	31.35	16.98	3.92	13.06	0.00	0.00	1.31
choriocarcinoma cell line:BeWo	10423-106C9	94.57	25.60	12.68	24.11	8.08	7.21	2.61
choriocarcinoma cell line:SCH	10785-110H2	66.17	22.55	9.12	17.25	3.82	3.57	0.86
choriocarcinoma cell line:T3M-3	10618-108G6	35.81	16.84	5.46	18.74	7.12	1.19	0.47
chorionic membrane cells, donor1	12238-129G6	24.50	4.56	2.85	12.82	2.56	0.00	0.85
chorionic membrane cells, donor2	12239-129G7	79.84	12.13	8.55	22.07	1.99	3.98	1.89
chorionic membrane cells, donor3	12240-129G8	45.06	9.34	2.75	20.88	2.75	1.10	0.55
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	10.10	2.02	0.00	0.00	0.00	3.03	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	15.75	5.57	1.15	2.88	1.54	1.34	0.58
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	21.54	1.90	2.11	5.07	1.27	0.84	1.06
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	2.05	0.51	0.00	0.77	0.00	0.26	0.26
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	2.18	0.73	0.00	0.73	0.00	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	1.63	0.00	0.20	0.61	0.20	0.00	0.00
chronic myelogenous leukemia cell line:K562	10454-106G4	4.71	0.29	0.29	1.18	0.88	0.00	0.00
chronic myelogenous leukemia cell line:KU812	10409-106B4	22.67	4.69	3.39	4.17	1.04	5.21	0.78
clear cell carcinoma cell line:JHOC-5	10638-108I8	39.54	8.00	4.11	9.83	2.74	5.71	0.23
clear cell carcinoma cell line:TEN	10636-108I6	66.63	9.72	4.86	24.64	3.99	4.16	1.04
colon carcinoma cell line:CACO-2	10513-107D9	37.89	5.13	2.93	16.29	2.01	1.28	0.55
colon carcinoma cell line:COLO-320	10420-106C6	123.91	17.48	9.50	15.96	6.46	8.36	3.42
colon, adult, donor1	10082-102B1	17.85	3.57	0.00	5.95	1.19	1.19	0.00
colon, adult, pool1	10014-101C5	20.45	2.70	1.18	5.17	2.35	1.41	0.35
colon, fetal, donor1	10070-101I7	19.78	3.09	2.47	6.80	1.85	0.62	0.62
common myeloid progenitor CMP, donor1	12130-128D6	77.92	9.17	4.58	13.75	0.00	13.75	0.00
common myeloid progenitor CMP, donor2	12134-128E1	50.07	0.00	25.04	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	22.10	0.00	1.27	11.05	0.42	0.42	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	28.83	1.36	1.36	5.43	0.45	0.75	0.30
cord blood derived cell line:COBL-a untreated	10449-106F8	29.61	1.55	1.13	7.61	0.28	1.41	0.56
corpus callosum, adult, pool1	10042-101F6	6.97	2.87	1.22	2.99	2.32	0.33	0.66
cruciate ligament, donor2	10295-104G7	10.54	1.62	0.00	8.10	2.43	0.81	0.00
diaphragm, fetal, donor1	10069-101I6	39.33	12.04	2.41	7.22	0.80	2.41	0.00
diencephalon, adult	10193-103E4	4.08	13.20	0.48	3.36	3.12	1.68	1.44
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	1.84	1.61	0.46	0.92	1.15	0.23	0.46
ductal cell carcinoma cell line:KLM-1	10438-106E6	52.06	11.54	1.54	17.18	5.90	1.28	1.03
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	60.66	11.31	9.63	17.81	1.69	1.93	1.44
ductus deferens, adult	10196-103E7	22.43	2.99	1.00	7.48	1.99	0.50	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	27.36	8.64	2.88	4.32	4.32	0.00	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	13.24	5.15	1.47	11.77	1.47	1.47	0.00
dura mater, adult, donor1	10041-101F5	32.87	4.29	2.64	4.54	2.31	2.23	1.49
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	33.53	9.33	3.33	11.99	1.78	1.11	0.00
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	51.87	17.05	7.74	15.33	4.73	1.86	1.00
embryonic pancreas cell line:1B2C6	10604-108F1	16.65	4.32	0.62	1.85	6.17	0.00	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	21.80	7.87	2.12	6.05	4.84	0.00	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	27.17	5.87	2.16	4.01	2.16	0.31	0.62
embryonic pancreas cell line:2C6	10603-108E9	18.39	1.31	0.00	10.51	2.63	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	45.25	7.71	6.03	11.40	4.36	0.00	0.67
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	61.62	30.81	5.26	7.61	13.59	8.16	1.09
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	6.43	2.57	0.96	1.45	1.77	0.48	0.00
epidermoid carcinoma cell line:A431	10426-106D3	40.46	9.89	4.34	9.45	3.56	2.56	1.45
epidermoid carcinoma cell line:Ca Ski	10431-106D8	43.33	11.11	3.63	13.86	4.29	1.10	0.66
epididymis, adult	10197-103E8	88.33	32.02	12.56	32.02	6.91	1.47	2.30
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	20.76	9.40	3.02	3.02	3.55	2.48	0.35
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	55.45	13.76	5.90	11.80	5.51	3.54	1.97
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	60.94	11.27	7.21	16.77	3.54	1.97	0.26
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	68.89	12.99	6.30	19.59	3.74	1.97	0.69
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	64.30	13.89	8.40	15.01	3.92	1.46	1.01
esophagus, adult, pool1	10015-101C6	15.29	2.23	1.06	3.50	1.27	0.53	0.21
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	158.05	25.05	12.27	29.56	5.26	5.51	2.38
eye - muscle inferior rectus, donor1	10272-104E2	14.49	0.00	0.00	12.07	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	2.10	0.00	0.00	8.42	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	4.46	2.98	0.00	7.44	1.49	0.00	0.00
eye - muscle superior, donor2	10297-104G9	13.76	4.59	1.15	9.17	1.15	1.15	0.00
eye - vitreous humor, donor1	10268-104D7	7.29	0.00	2.91	4.37	1.46	0.00	0.00
eye, fetal, donor1	10054-101G9	23.39	4.83	2.80	7.37	1.53	1.27	0.25
fibrosarcoma cell line:HT-1080	10758-110E2	40.78	10.26	7.44	8.21	1.67	4.10	1.41
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	49.15	6.89	6.17	20.89	4.99	3.09	0.95
frontal lobe, adult, pool1	10040-101F4	7.88	4.88	1.22	2.35	2.53	2.16	0.84
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	39.93	11.71	2.10	15.01	5.40	1.20	0.60
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	110.82	48.74	12.07	37.85	11.25	2.47	2.47
gall bladder, adult	10198-103E9	17.38	3.86	1.45	6.52	0.48	1.45	0.72
gamma delta positive T cells, donor1	11937-126A2	10.20	2.68	1.07	2.15	2.68	1.07	1.07
gamma delta positive T cells, donor2	11938-126A3	5.98	0.37	0.00	2.61	0.75	0.37	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	15.84	2.32	1.90	7.60	1.06	0.42	0.00
gastric adenocarcinoma cell line:MKN45	10612-108F9	67.70	9.48	5.03	35.01	5.22	0.97	0.19
gastric cancer cell line:AZ521	10549-107H9	54.60	38.69	11.31	17.71	11.80	8.03	2.13
gastric cancer cell line:GSS	10560-108A2	64.98	63.15	2.75	29.29	11.90	3.66	1.83
gastrointestinal carcinoma cell line:ECC12	10615-108G3	35.64	7.08	5.94	18.05	0.46	3.66	1.60
giant cell carcinoma cell line:LU65	10487-107B1	17.44	1.38	1.03	4.02	1.15	1.26	0.57
giant cell carcinoma cell line:Lu99B	10433-106E1	60.18	7.00	5.32	9.66	3.08	2.66	1.40
glassy cell carcinoma cell line:HOKUG	10688-109F4	25.19	2.24	0.75	9.48	1.50	1.25	0.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	54.15	10.03	2.64	13.30	3.80	5.07	1.16
glioblastoma cell line:A172, tech_rep2	10444-106F3	54.91	9.97	7.30	9.27	3.23	5.20	1.97
glioblastoma cell line:T98G	10485-107A8	74.83	6.95	3.97	24.06	2.65	1.66	0.66
glioma cell line:GI-1	10413-106B8	65.31	21.38	15.52	10.84	4.10	3.22	1.76
globus pallidus - adult, donor10196	10175-103C4	8.75	6.56	2.19	6.56	2.92	2.92	0.00
globus pallidus, adult, donor10252	10161-103A8	9.03	2.44	1.46	3.42	2.20	0.00	1.22
globus pallidus, adult, donor10258	10367-105F7	1.37	4.11	0.00	4.11	4.11	0.00	0.00
globus pallidus, newborn, donor10223	10364-105F4	12.26	6.40	1.07	6.93	4.80	0.00	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	88.10	2.45	9.79	17.13	4.89	22.02	4.89
granulocyte macrophage progenitor, donor2	12135-128E2	10.93	0.00	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	0.00	0.00	5.23	5.23	0.00	5.23	0.00
granulosa cell tumor cell line:KGN	10624-108H3	42.88	8.96	10.24	13.44	2.24	5.44	2.56
hIPS +CCl2, biol_rep1	14383-156B9	16.53	16.53	0.46	19.28	3.67	2.30	0.46
hIPS +CCl2, biol_rep2	14384-156C1	13.72	13.72	1.83	22.86	1.37	1.83	0.46
hIPS +CCl2, biol_rep3	14385-156C2	13.53	15.46	0.64	21.26	1.93	1.93	0.64
hIPS, biol_rep1	14380-156B6	4.31	11.50	0.00	4.31	0.00	1.44	0.00
hIPS, biol_rep2	14381-156B7	11.66	10.29	1.37	13.72	0.69	0.69	1.37
hIPS, biol_rep3	14382-156B8	2.21	4.41	0.00	12.14	1.10	1.10	0.00
hairy cell leukemia cell line:Mo	10712-109I1	7.47	0.29	0.86	2.01	0.00	0.86	0.00
heart - mitral valve, adult	10205-103F7	24.81	2.99	0.00	4.78	1.79	1.20	0.30
heart - pulmonic valve, adult	10206-103F8	17.52	4.18	1.57	4.71	1.31	0.26	0.26
heart - tricuspid valve, adult	10207-103F9	57.45	10.82	6.66	27.48	4.16	1.67	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	17.14	7.55	1.02	4.90	2.24	0.41	0.41
heart, adult, diseased, donor1	10051-101G6	7.24	0.85	0.00	2.55	0.43	0.43	0.00
heart, adult, pool1	10016-101C7	26.68	3.68	2.07	8.05	0.46	1.15	0.00
heart, fetal, pool1	10046-101G1	17.66	4.21	1.85	3.70	1.13	1.03	0.62
hepatic mesenchymal tumor cell line:LI90	10778-110G4	79.29	18.82	13.58	25.61	3.39	4.32	2.16
hepatoblastoma cell line:HuH-6	10633-108I3	38.05	4.76	2.38	26.16	2.38	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	9.83	2.65	1.66	2.87	0.55	1.10	0.66
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	9.22	1.46	1.46	2.79	0.49	0.73	0.12
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	12.73	2.02	1.62	2.83	0.81	1.72	0.20
hepatoma cell line:Li-7	10484-107A7	30.58	5.23	2.00	12.90	1.78	1.00	0.56
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	20.90	7.74	7.84	5.93	1.61	3.42	1.51
hippocampus - adult, donor10196	10169-103B7	7.57	6.62	0.95	7.57	2.84	3.79	0.00
hippocampus, adult, donor10252	10153-102I9	7.76	5.92	1.02	2.45	3.06	1.63	0.61
hippocampus, adult, donor10258	10374-105G5	1.49	4.48	0.00	4.48	0.50	0.50	0.50
hippocampus, newborn, donor10223	10363-105F3	6.34	5.64	0.35	3.52	3.17	4.23	0.35
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	33.57	33.57	3.05	12.82	6.71	3.05	2.44
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	25.13	28.47	7.27	8.25	7.85	2.16	1.18
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	21.58	28.44	3.81	11.17	6.86	2.54	2.03
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	42.85	31.01	3.95	20.30	1.69	2.26	2.26
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	43.64	26.85	9.81	12.91	4.13	3.61	1.55
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	46.31	24.67	6.45	22.02	5.31	2.66	1.90
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	37.95	19.27	3.50	14.01	7.59	0.88	1.17
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	34.68	28.44	8.19	8.40	8.62	1.72	1.08
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	50.05	25.86	6.26	21.69	8.34	2.09	0.83
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	46.88	29.36	7.58	20.60	5.21	2.84	1.89
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	47.41	31.66	9.64	15.91	6.27	3.21	2.25
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	65.31	22.22	8.75	16.16	4.04	3.37	2.02
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	20.97	14.08	6.10	6.42	4.07	3.29	1.72
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	21.62	9.33	6.39	7.37	4.42	5.40	1.97
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	20.95	6.98	3.49	8.73	0.00	4.36	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	54.98	9.16	11.45	18.14	2.29	3.05	1.34
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	46.22	12.65	12.21	23.11	1.74	0.87	2.62
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	36.98	7.50	2.50	14.99	1.00	1.00	1.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	48.79	15.64	9.98	8.29	4.14	1.70	0.94
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	44.11	21.37	14.55	13.19	7.73	4.09	1.82
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	45.73	12.53	6.89	12.53	5.95	2.82	1.25
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	45.56	23.35	11.59	12.08	6.21	3.59	2.45
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	42.39	20.61	13.93	11.61	4.35	4.35	2.90
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	43.64	17.94	9.27	17.34	5.08	2.69	2.39
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	35.84	12.93	6.47	11.64	2.96	5.91	1.29
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	29.38	16.55	9.98	12.84	2.85	3.71	2.85
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	37.97	12.66	8.98	17.15	4.08	4.90	0.41
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	39.08	11.62	9.86	21.83	1.76	2.46	0.35
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	42.76	15.52	6.02	18.05	0.95	3.17	1.58
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	46.00	14.22	6.36	22.39	1.51	2.42	0.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	42.40	13.96	8.27	20.68	2.59	5.69	1.55
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	41.84	14.61	11.29	23.91	4.65	7.31	1.33
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	53.10	17.70	8.98	20.01	4.10	4.10	1.28
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	56.24	16.87	11.25	16.36	3.32	8.18	2.56
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	54.52	21.20	14.39	26.50	6.82	10.60	4.54
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	55.11	16.47	9.75	20.84	8.40	6.39	3.70
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	30.91	13.77	8.69	11.11	1.69	6.52	1.45
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	32.09	12.92	4.46	15.15	1.78	4.01	1.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	35.12	16.59	6.83	9.27	0.98	5.85	2.93
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	44.93	7.64	8.25	22.62	0.92	3.97	0.61
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	185.43	22.77	3.25	136.64	3.25	6.51	3.25
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	54.61	9.27	4.96	20.52	3.31	2.32	0.33
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	44.88	11.49	8.76	20.25	4.93	4.38	1.09
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	48.13	10.86	7.24	19.90	4.70	4.70	1.09
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	46.62	11.03	5.34	16.73	2.85	4.27	1.07
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	36.99	10.74	3.58	22.67	3.58	5.97	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	73.67	14.76	12.59	26.54	4.20	8.67	2.44
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	51.72	16.16	6.73	14.01	2.16	5.66	2.16
immature langerhans cells, donor1	11904-125F5	1.94	0.24	0.00	0.24	0.00	0.24	0.48
immature langerhans cells, donor2	11905-125F6	3.17	0.00	0.00	3.96	0.79	0.79	0.79
insula, adult, pool1	10039-101F3	7.85	5.30	1.04	1.99	3.12	2.08	0.95
keratoacanthoma cell line:HKA-1	10791-110H8	8.78	0.65	0.00	3.58	0.33	0.33	0.00
kidney, adult, pool1	10017-101C8	15.92	2.20	1.20	5.01	1.10	0.90	0.50
kidney, fetal, pool1	10045-101F9	21.15	5.45	2.05	7.00	2.41	2.19	1.20
large cell lung carcinoma cell line:IA-LM	10509-107D5	108.36	26.42	13.78	32.66	6.11	10.08	4.54
large cell lung carcinoma cell line:NCI-H460	10839-111E2	53.91	10.09	2.90	17.14	4.42	1.66	0.83
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	15.96	3.85	0.73	6.61	2.20	0.18	0.92
left atrium, adult, donor1	10079-102A7	15.26	3.81	2.18	7.63	1.63	0.54	0.54
left ventricle, adult, donor1	10078-102A6	18.71	0.51	1.52	3.54	0.00	1.01	0.00
leiomyoblastoma cell line:G-402	10721-110A1	68.40	19.15	6.29	15.32	2.46	1.64	1.92
leiomyoma cell line:10964C	10569-108B2	65.02	28.74	13.65	19.04	4.67	5.75	5.03
leiomyoma cell line:15242A	10570-108B3	62.50	10.87	8.15	19.57	3.80	7.07	2.72
leiomyoma cell line:15425	10571-108B4	76.00	17.48	8.50	20.40	2.91	6.56	2.19
leiomyosarcoma cell line:Hs 5.T	10722-110A2	57.14	31.75	6.35	19.05	0.00	0.00	6.35
lens epithelial cell line:SRA 01/04	10647-109A8	19.87	5.23	1.05	4.18	0.00	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	26.21	7.08	4.13	7.20	2.60	2.01	1.18
liposarcoma cell line:KMLS-1	10782-110G8	34.52	6.87	5.00	8.44	1.87	2.19	0.62
liposarcoma cell line:SW 872	10726-110A6	58.97	27.41	7.31	14.74	7.31	1.46	1.71
liver, adult, pool1	10018-101C9	38.41	2.76	0.97	11.34	2.27	1.30	0.49
liver, fetal, pool1	10086-102B5	16.93	0.00	0.00	5.64	0.94	0.94	0.00
locus coeruleus - adult, donor10196	10182-103D2	5.40	1.60	0.73	2.19	0.58	1.31	0.15
locus coeruleus, adult, donor10252	10165-103B3	5.35	2.58	1.29	2.21	1.11	0.18	0.74
locus coeruleus, adult, donor10258	10375-105G6	8.75	3.39	0.85	3.67	1.97	1.69	0.28
locus coeruleus, newborn, donor10223	10362-105F2	9.67	2.10	0.00	6.73	0.84	1.26	0.42
lung adenocarcinoma cell line:A549	10499-107C4	68.78	7.75	6.92	17.58	2.21	2.21	0.69
lung adenocarcinoma cell line:PC-14	10408-106B3	54.46	8.27	1.38	28.27	8.96	3.45	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	52.73	18.45	2.37	10.68	8.17	2.11	0.53
lung, adult, pool1	10019-101D1	19.14	2.48	1.89	4.61	1.30	0.71	0.47
lung, fetal, donor1	10068-101I5	26.26	9.70	0.57	15.98	1.71	1.14	0.57
lung, right lower lobe, adult, donor1	10075-102A3	20.62	2.29	2.29	5.96	1.37	0.46	0.00
lymph node, adult, donor1	10077-102A5	16.57	3.31	1.89	5.21	0.00	1.42	0.47
lymphangiectasia cell line:DS-1	10727-110A7	14.25	2.63	1.32	3.73	1.10	1.75	1.10
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	4.38	0.60	0.60	0.60	0.45	1.21	1.06
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	24.64	3.40	2.55	10.19	1.70	0.85	0.00
mature adipocyte, donor1	12231-129F8	28.86	1.78	0.89	9.32	1.78	0.89	0.00
mature adipocyte, donor2	12232-129F9	18.68	2.70	0.42	6.23	2.70	0.62	0.21
mature adipocyte, donor3	12233-129G1	16.59	2.61	0.00	4.03	1.66	0.71	0.24
mature adipocyte, donor4	12234-129G2	15.27	1.84	0.26	4.74	1.05	0.26	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	49.32	13.58	4.77	15.73	5.72	3.57	1.43
medial frontal gyrus - adult, donor10196	10170-103B8	3.38	1.13	1.13	2.26	1.13	2.26	1.13
medial frontal gyrus, adult, donor10252	10150-102I6	7.36	2.57	0.92	2.94	1.84	1.10	0.18
medial frontal gyrus, adult, donor10258	10368-105F8	7.62	1.59	0.95	2.86	1.27	1.27	0.32
medial frontal gyrus, newborn, donor10223	10352-105E1	7.68	3.84	0.43	1.71	1.71	1.71	0.00
medial temporal gyrus - adult, donor10196	10183-103D3	8.61	6.24	0.84	1.86	1.86	2.19	1.18
medial temporal gyrus, adult, donor10252	10156-103A3	7.43	2.76	1.27	2.55	1.70	1.06	0.00
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	3.85	1.93	1.93	3.85	1.93	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	0.00	14.35	0.00	14.35	14.35	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	5.38	4.31	0.00	2.15	2.15	2.87	0.00
medulla oblongata - adult, donor10196	10174-103C3	16.22	3.24	0.00	5.84	1.30	0.65	0.00
medulla oblongata, adult, donor10252	10155-103A2	10.84	4.80	1.08	4.18	2.01	0.62	0.31
medulla oblongata, adult, pool1	10038-101F2	8.82	4.00	1.06	2.94	1.71	0.98	0.49
medulla oblongata, newborn, donor10223	10361-105F1	16.32	6.60	1.04	11.11	4.86	1.04	0.69
medulloblastoma cell line:D283 Med	10838-111E1	118.90	31.88	15.06	37.20	4.43	11.73	3.99
medulloblastoma cell line:ONS-76	10759-110E3	10.39	1.96	1.96	4.89	1.35	0.24	0.49
melanoma cell line:COLO 679	10514-107E1	39.67	4.02	3.59	11.50	1.87	1.72	0.86
melanoma cell line:G-361	10465-106H6	65.42	7.60	2.44	20.09	2.71	2.99	1.36
meningioma cell line:HKBMM	10691-109F7	13.57	1.27	0.72	2.71	0.54	0.00	0.36
merkel cell carcinoma cell line:MKL-1	10843-111E6	29.96	31.72	6.17	8.81	7.05	11.46	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	16.85	29.03	6.22	4.67	9.59	2.07	2.85
mesenchymal precursor cell - adipose, donor1	11747-123G1	125.51	31.15	13.96	21.17	5.06	7.52	2.92
mesenchymal precursor cell - adipose, donor2	11748-123G2	101.07	36.17	14.18	18.00	4.00	3.45	3.27
mesenchymal precursor cell - adipose, donor3	11749-123G3	90.69	26.50	8.70	66.67	2.07	7.45	1.24
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	83.86	26.27	14.47	13.91	3.65	4.50	3.37
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	102.45	29.08	17.91	18.49	3.27	8.86	3.27
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	73.57	22.21	5.55	27.76	5.55	4.86	1.39
mesenchymal precursor cell - cardiac, donor1	11752-123G6	156.87	33.30	29.35	47.20	2.92	7.90	2.92
mesenchymal precursor cell - cardiac, donor2	11753-123G7	93.05	28.64	12.65	21.39	2.76	5.29	2.19
mesenchymal precursor cell - cardiac, donor3	11754-123G8	73.22	22.02	7.56	13.13	4.51	5.04	1.19
mesenchymal precursor cell - cardiac, donor4	11755-123G9	70.22	17.15	9.59	16.61	2.16	5.94	1.62
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	87.63	18.92	12.52	14.51	2.28	7.26	2.56
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	119.89	31.29	21.41	67.19	6.92	5.93	3.62
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	96.45	26.01	12.59	16.60	3.74	4.98	1.52
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	94.60	23.74	11.17	33.16	4.19	6.63	2.09
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	95.34	19.80	11.84	19.80	3.27	6.33	2.65
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	61.83	9.71	7.91	23.01	2.16	1.80	0.72
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	67.86	23.79	8.69	10.24	5.17	5.69	2.38
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	53.35	10.72	7.75	25.54	3.19	2.51	1.14
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	78.46	20.14	6.29	40.28	6.71	7.97	1.68
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	89.66	18.53	11.21	16.74	2.99	5.98	1.94
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	74.93	21.71	10.94	14.44	5.16	5.43	2.28
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	78.79	25.40	17.30	28.72	4.05	2.21	5.15
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	68.68	14.88	8.87	29.19	4.58	3.43	1.72
mesenchymal stem cell line:Hu5/E18	10568-108B1	41.68	7.58	2.53	8.42	2.11	4.21	1.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	74.44	18.27	5.94	15.07	2.28	1.83	1.83
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	70.60	22.51	6.65	28.14	3.58	3.58	1.28
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	75.12	17.01	8.90	27.22	3.66	6.02	1.83
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	63.47	18.49	7.70	27.73	5.55	3.39	1.54
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	55.07	13.42	10.12	24.48	2.59	2.59	1.41
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	58.89	24.71	7.11	29.45	2.37	2.37	0.68
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	57.37	27.90	6.29	23.19	3.14	1.96	3.14
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	61.63	21.32	5.56	33.83	2.32	1.39	1.39
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	96.61	0.00	0.00	48.30	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	71.24	21.34	9.23	35.19	5.48	4.04	1.73
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	60.24	22.98	7.81	29.67	3.79	4.24	1.56
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	66.82	18.03	9.13	23.79	3.61	4.81	3.12
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	77.00	16.87	7.33	23.47	1.47	5.13	1.47
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	65.45	17.45	5.03	26.85	3.02	2.35	1.68
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	57.72	18.42	9.83	25.38	2.87	2.87	3.28
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	64.00	23.20	9.02	21.91	2.58	3.87	1.72
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	62.89	30.08	0.00	41.02	8.20	5.47	5.47
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	98.13	25.82	10.33	30.99	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	76.65	23.38	5.52	29.23	3.25	4.22	1.62
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	80.02	23.28	5.82	27.64	4.36	2.91	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	90.62	24.52	12.26	38.38	3.20	3.20	2.13
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	79.32	24.53	7.36	30.26	4.91	3.27	1.64
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	83.57	23.71	7.77	33.82	3.89	3.89	1.55
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	88.15	6.30	6.30	44.07	4.20	2.10	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	66.56	24.84	2.98	27.82	4.97	2.98	1.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	85.81	19.07	9.53	38.14	0.00	0.00	4.77
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	81.24	18.97	7.71	34.39	2.96	0.59	2.37
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	81.64	20.71	7.31	35.34	1.22	6.09	2.44
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	54.10	0.00	0.00	54.10	27.05	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	81.71	24.07	5.70	38.64	4.43	5.70	0.63
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	79.67	22.76	7.93	41.73	4.48	4.83	1.03
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	75.22	25.79	2.15	30.09	4.30	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	67.86	35.93	7.98	15.97	0.00	0.00	3.99
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	51.66	27.55	10.33	24.11	0.00	3.44	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	79.46	19.56	9.78	23.23	2.04	2.04	1.63
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	98.51	23.83	9.53	21.45	0.79	0.79	1.59
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	54.83	9.43	11.20	19.45	4.13	1.77	1.77
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	61.09	14.03	5.92	22.75	3.43	3.74	1.56
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	73.52	20.05	4.01	20.05	1.34	1.34	2.67
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	41.39	11.83	2.37	21.29	2.37	1.18	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	46.22	7.70	5.14	17.98	5.14	0.00	5.14
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	61.96	8.95	4.13	24.09	0.69	2.07	2.07
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	56.41	11.88	6.93	28.70	2.97	2.47	0.49
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	49.35	8.97	2.24	28.04	1.12	2.24	1.12
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	50.89	13.36	7.00	25.44	3.82	1.27	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	47.55	10.88	7.66	22.97	3.22	1.61	1.61
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	61.06	8.72	15.26	21.81	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	50.68	8.87	2.53	26.61	2.53	3.80	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	55.83	20.03	6.07	35.81	1.21	1.21	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	103.94	18.08	13.56	40.67	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	60.95	18.94	9.06	31.30	2.47	3.29	0.82
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	71.04	10.91	5.56	30.95	0.79	3.37	0.99
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	55.49	14.93	3.89	24.99	0.97	1.62	1.62
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	47.88	7.13	3.06	21.39	1.02	1.02	2.04
mesodermal tumor cell line:HIRS-BM	10696-109G3	69.63	3.87	8.51	23.99	0.00	3.09	0.77
mesothelioma cell line:ACC-MESO-1	10493-107B7	48.19	12.05	3.54	8.98	7.09	1.18	0.71
mesothelioma cell line:ACC-MESO-4	10494-107B8	84.10	15.06	9.04	16.68	7.65	3.71	0.93
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	47.01	12.82	0.00	17.09	4.27	4.27	4.27
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	33.70	5.75	2.67	10.69	2.06	2.26	0.10
mesothelioma cell line:Mero-25	10850-111F4	35.63	9.76	6.81	17.48	0.91	3.86	0.91
mesothelioma cell line:Mero-41	10851-111F5	64.54	26.16	5.38	20.05	7.82	2.44	1.71
mesothelioma cell line:Mero-48a	10852-111F6	22.59	5.98	2.21	11.96	1.11	3.32	0.89
mesothelioma cell line:Mero-82	10853-111F7	44.68	7.36	2.63	26.28	1.84	2.63	0.00
mesothelioma cell line:Mero-83	10854-111F8	22.64	8.17	1.53	8.51	1.53	2.21	0.85
mesothelioma cell line:Mero-84	10855-111F9	19.21	6.82	1.52	6.07	1.77	2.27	0.76
mesothelioma cell line:Mero-95	10856-111G1	24.85	10.97	2.07	7.45	5.80	1.04	0.83
mesothelioma cell line:NCI-H2052	10847-111F1	49.86	12.42	5.80	28.66	3.98	1.33	0.99
mesothelioma cell line:NCI-H226	10846-111E9	44.34	4.71	4.71	17.38	1.27	3.08	0.90
mesothelioma cell line:NCI-H2452	10848-111F2	64.23	7.52	1.37	26.14	3.93	1.88	0.34
mesothelioma cell line:NCI-H28	10845-111E8	32.06	4.33	3.82	16.29	4.83	2.80	1.02
mesothelioma cell line:No36	10857-111G2	19.90	3.91	2.28	15.01	0.98	1.30	0.33
mesothelioma cell line:ONE58	10858-111G3	48.23	5.96	3.79	26.55	2.17	3.25	0.00
migratory langerhans cells, donor1	11901-125F2	7.29	0.77	0.96	5.18	0.77	0.96	0.00
migratory langerhans cells, donor2	11902-125F3	8.30	0.98	0.12	3.18	0.24	0.61	0.24
migratory langerhans cells, donor3	11903-125F4	12.56	0.54	0.90	5.74	0.36	1.08	1.26
mixed mullerian tumor cell line:HTMMT	10689-109F5	51.26	12.08	8.81	20.57	4.24	1.31	1.63
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	42.60	11.23	9.54	12.29	1.70	2.76	1.27
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	36.40	5.53	2.53	14.05	1.84	0.23	0.69
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	9.70	0.95	1.14	2.09	0.38	0.19	0.38
myelodysplastic syndrome cell line:SKM-1	10772-110F7	20.14	4.07	4.62	4.07	2.96	1.29	2.03
myeloma cell line:PCM6	10474-106I6	17.00	0.99	0.99	7.91	0.40	0.20	0.79
myxofibrosarcoma cell line:MFH-ino	10600-108E6	26.38	16.74	3.04	8.12	3.55	2.54	1.01
myxofibrosarcoma cell line:NMFH-1	10684-109E9	29.03	6.47	3.53	11.96	1.18	2.94	0.59
nasal epithelial cells, donor1, tech_rep1	12226-129F3	18.39	1.56	1.00	5.68	1.45	0.45	0.22
nasal epithelial cells, donor1, tech_rep2	12226-129F3	18.16	1.47	0.96	5.74	1.25	0.44	0.07
nasal epithelial cells, donor2	12227-129F4	22.08	2.76	0.55	6.62	3.86	0.00	0.00
neuroblastoma cell line:CHP-134	10508-107D4	64.42	19.33	10.81	13.11	7.59	8.97	3.68
neuroblastoma cell line:NB-1	10539-107G8	30.49	9.92	5.05	5.43	2.06	4.68	2.06
neuroblastoma cell line:NBsusSR	10607-108F4	18.77	15.39	16.45	4.85	5.69	5.69	2.74
neuroblastoma cell line:NH-12	10555-107I6	13.60	4.47	1.86	3.35	3.54	0.56	0.56
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	10.44	17.08	5.46	1.42	4.74	7.12	0.71
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	15.36	12.35	4.59	1.90	1.74	5.23	1.90
neuroectodermal tumor cell line:TASK1	10774-110F9	25.56	22.34	7.45	3.02	5.23	1.21	3.02
neuroepithelioma cell line:SK-N-MC	10728-110A8	8.90	22.89	5.09	1.27	5.09	5.09	1.27
neurofibroma cell line:Hs 53.T	10729-110A9	70.00	22.09	12.78	29.54	5.06	5.59	1.86
neutrophil PMN, donor1	12133-128D9	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	0.00	0.00	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	54.96	3.89	15.56	8.29	1.35	2.54	3.04
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	0.00	0.00	0.00	0.00	0.00	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	95.86	15.07	15.39	19.56	0.96	6.73	5.13
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	65.43	10.51	5.52	14.71	2.63	2.89	1.05
nucleus accumbens, adult, pool1	10037-101F1	7.59	18.09	2.91	2.34	6.84	7.50	1.31
occipital cortex - adult, donor10196	10172-103C1	8.24	6.18	2.06	4.12	0.00	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	6.98	1.88	0.81	3.49	1.07	0.81	0.54
occipital cortex, newborn, donor10223	10355-105E4	6.55	2.18	0.36	3.64	1.82	2.55	0.73
occipital lobe, adult, donor1	10076-102A4	12.33	5.25	2.10	2.89	1.84	1.31	0.52
occipital lobe, fetal, donor1	10073-102A1	6.44	3.00	1.29	2.15	1.29	1.72	2.15
occipital pole, adult, pool1	10036-101E9	5.20	2.68	0.63	1.50	1.18	1.66	0.08
olfactory region, adult	10195-103E6	3.44	2.67	0.57	2.29	1.34	0.57	0.38
optic nerve, donor1	10277-104E7	4.00	8.00	0.00	4.00	2.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	36.22	7.63	2.96	11.39	3.42	2.39	0.57
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	34.90	9.07	5.77	7.97	4.40	1.24	0.69
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	23.03	3.56	2.03	4.57	1.69	0.34	0.68
oral squamous cell carcinoma cell line:SAS	10544-107H4	16.40	2.66	0.81	6.93	2.19	0.35	0.92
osteoclastoma cell line:Hs 706.T	10704-109H2	72.02	16.76	9.11	27.63	5.29	4.41	2.35
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	40.18	10.28	6.54	21.49	0.93	0.93	0.93
osteosarcoma cell line:HS-Os-1	10558-107I9	34.57	2.12	3.61	8.27	0.64	0.64	0.64
ovary, adult, pool1	10020-101D2	36.69	16.25	7.34	4.89	4.80	2.62	2.10
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	58.30	22.18	17.97	18.33	1.65	7.88	2.75
pancreas, adult, donor1	10049-101G4	10.35	3.76	0.00	6.58	0.94	1.88	0.94
pancreatic carcinoma cell line:NOR-P1	10698-109G5	51.99	20.69	3.63	24.32	7.55	1.40	1.12
papillary adenocarcinoma cell line:8505C	10437-106E5	63.37	12.78	3.58	19.59	7.15	0.68	1.02
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	53.65	6.79	1.66	13.25	4.14	1.49	0.17
paracentral gyrus, adult, pool1	10035-101E8	6.86	3.48	1.10	1.28	1.65	2.47	0.73
parietal cortex, adult, donor10258	10373-105G4	2.94	9.54	1.47	5.14	0.73	5.14	1.47
parietal lobe - adult, donor10196	10171-103B9	6.58	2.82	0.00	9.40	0.94	0.94	0.00
parietal lobe, adult, donor10252	10157-103A4	3.14	2.28	0.00	2.85	2.57	0.29	0.00
parietal lobe, adult, pool1	10034-101E7	7.14	3.97	1.41	1.76	1.32	1.67	0.79
parietal lobe, fetal, donor1	10072-101I9	9.70	4.85	0.97	0.00	1.94	0.97	0.00
parietal lobe, newborn, donor10223	10356-105E5	4.49	6.73	0.00	3.36	2.24	1.12	0.37
parotid gland, adult	10199-103F1	40.08	17.27	2.47	25.28	5.55	1.23	1.23
penis, adult	10200-103F2	18.80	3.22	2.69	8.06	1.07	0.54	0.00
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	7.25	4.28	0.74	1.30	5.02	0.74	0.37
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	99.36	10.34	9.03	32.34	3.93	4.08	1.60
pineal gland - adult, donor10196	10179-103C8	26.45	7.74	4.52	14.19	1.29	4.52	1.94
pineal gland, adult, donor10252	10160-103A7	15.99	2.37	3.55	8.29	1.18	5.33	1.18
pineal gland, adult, donor10258	10377-105G8	21.95	3.14	0.63	18.19	1.25	2.51	3.14
pituitary gland - adult, donor10196	10180-103C9	79.93	44.52	23.27	40.47	3.04	11.13	2.02
pituitary gland, adult, donor10252	10162-103A9	65.67	31.79	18.24	30.23	5.73	5.21	1.56
pituitary gland, adult, donor10258	10378-105G9	63.84	19.58	6.81	50.22	1.70	4.26	4.26
placenta, adult, pool1	10021-101D3	44.18	3.44	2.90	13.55	2.04	0.97	0.54
plasma cell leukemia cell line:ARH-77	10840-111E3	16.02	5.16	1.99	6.22	1.85	2.25	0.79
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	73.77	15.10	9.96	24.28	1.87	1.87	1.56
pons, adult, pool1	10033-101E6	3.96	1.12	0.26	1.03	0.69	0.34	0.17
postcentral gyrus, adult, pool1	10032-101E5	5.84	3.57	1.31	1.39	1.13	1.57	0.87
promyelocytes/myelocytes PMC, donor1	12132-128D8	52.28	4.18	2.09	14.64	6.27	4.18	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	0.00	0.00	0.00	5.51	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	11.74	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	25.64	10.63	3.79	4.66	5.54	2.33	0.87
prostate cancer cell line:PC-3	10439-106E7	45.74	8.71	4.90	9.62	4.17	2.18	0.73
prostate, adult, pool1	10022-101D4	28.66	5.26	1.72	8.16	2.45	1.81	0.63
putamen, adult, donor10196	10176-103C5	8.03	54.06	5.43	2.60	17.94	18.41	4.25
putamen, adult, donor10252	10152-102I8	7.84	13.73	0.00	7.84	9.80	3.92	3.92
putamen, adult, donor10258, tech_rep1	10372-105G3	4.37	6.56	0.00	9.84	3.28	3.28	2.19
putamen, adult, donor10258, tech_rep2	10372-105G3	7.49	26.09	1.93	2.66	9.42	9.91	4.83
putamen, newborn, donor10223	10365-105F5	5.25	3.75	0.00	3.00	0.75	1.50	0.00
rectal cancer cell line:TT1TKB	10469-106I1	27.64	2.91	1.45	9.60	2.04	0.58	0.29
rectum, fetal, donor1	10067-101I4	62.59	12.52	2.78	15.30	2.78	2.78	1.39
renal cell carcinoma cell line:OS-RC-2	10411-106B6	73.78	16.11	4.24	20.78	4.45	3.82	0.85
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	45.15	10.77	3.31	7.04	9.11	0.83	0.00
retina, adult, pool1	10030-101E3	16.30	3.78	1.69	5.07	1.59	1.59	0.70
retinoblastoma cell line:Y79	10475-106I7	56.12	22.08	15.59	7.79	6.75	10.91	4.68
rhabdomyosarcoma cell line:KYM-1	10787-110H4	44.51	31.11	9.59	7.38	4.43	2.70	1.84
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	191.50	25.31	21.65	39.93	1.69	5.06	1.97
sacrococcigeal teratoma cell line:HTST	10695-109G2	81.85	19.70	10.61	18.19	3.03	4.55	3.03
salivary acinar cells, donor1	11771-123I7	24.93	4.05	0.65	7.77	2.91	0.49	0.81
salivary acinar cells, donor2	11772-123I8	16.52	2.07	0.83	5.09	1.51	0.41	0.00
salivary acinar cells, donor3	11773-123I9	8.61	1.32	0.66	7.94	0.66	0.00	0.00
salivary gland, adult, pool1	10093-102C3	19.45	5.15	1.14	29.17	4.58	1.14	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	29.26	9.44	3.54	4.97	4.81	1.85	1.52
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	28.33	11.40	4.58	4.47	4.35	1.65	3.06
seminal vesicle, adult	10201-103F3	27.51	10.05	1.06	12.17	3.17	0.00	0.00
serous adenocarcinoma cell line:JHOS-2	10639-108I9	37.41	9.23	2.19	21.13	4.13	0.97	1.21
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	33.47	6.54	2.01	15.10	2.01	3.52	0.50
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	34.12	4.01	1.00	11.04	0.00	1.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	55.21	15.45	8.87	18.27	4.30	3.76	1.48
signet ring carcinoma cell line:Kato III	10436-106E4	21.44	2.76	1.33	7.41	2.43	0.44	0.44
signet ring carcinoma cell line:NUGC-4	10483-107A6	41.93	5.16	1.16	19.87	1.81	1.03	0.39
skeletal muscle - soleus muscle, donor1	10282-104F3	5.67	1.42	0.00	8.51	0.00	0.00	0.00
skeletal muscle, adult, pool1	10023-101D5	16.19	1.68	0.96	5.04	1.08	0.72	0.60
skeletal muscle, fetal, donor1	10066-101I3	42.21	10.05	3.02	4.02	2.01	3.02	1.01
skin, adult, donor1	10074-102A2	33.93	0.00	0.00	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	49.24	8.21	4.42	18.31	0.63	3.79	1.89
small cell cervical cancer cell line:HCSC-1	10800-110I8	21.01	7.34	5.34	3.34	3.67	2.67	1.33
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	39.40	13.55	12.29	21.12	2.84	2.21	1.58
small cell lung carcinoma cell line:DMS 144	10841-111E4	273.32	326.13	48.77	55.70	100.42	92.13	15.23
small cell lung carcinoma cell line:LK-2	10541-107H1	78.46	7.58	5.93	22.09	2.14	2.47	0.82
small cell lung carcinoma cell line:NCI-H82	10842-111E5	44.07	27.83	9.49	9.17	9.81	4.83	2.57
small cell lung carcinoma cell line:WA-hT	10562-108A4	31.38	4.58	3.27	18.52	1.96	2.62	0.65
small intestine, adult, pool1	10024-101D6	16.36	2.63	0.72	4.06	1.31	0.72	0.48
small intestine, fetal, donor1	10064-101I1	32.43	5.90	3.44	4.91	0.74	3.19	1.47
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	5.13	1.54	0.51	3.59	1.03	0.00	0.51
smooth muscle, adult, pool1	10048-101G3	18.35	3.10	1.29	7.24	0.26	0.78	0.26
somatostatinoma cell line:QGP-1	10781-110G7	28.68	2.68	0.00	15.28	1.88	0.54	0.80
spinal cord - adult, donor10196	10181-103D1	11.70	5.05	1.61	5.28	2.29	0.92	0.92
spinal cord, adult, donor10252	10159-103A6	14.98	6.70	2.76	5.52	2.37	1.18	0.00
spinal cord, adult, donor10258	10369-105F9	4.15	2.08	0.00	11.07	2.08	0.69	0.00
spinal cord, fetal, donor1	10056-101H2	32.32	12.20	4.27	10.37	6.10	3.05	0.61
spinal cord, newborn, donor10223	10359-105E8	19.29	1.84	0.46	5.97	2.30	0.46	0.00
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	88.42	16.58	12.40	34.05	4.93	4.03	3.73
spleen, adult, pool1	10025-101D7	14.10	1.43	1.65	4.07	0.99	0.88	0.44
spleen, fetal, pool1	10044-101F8	12.55	1.75	0.72	4.29	0.79	0.79	0.24
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	34.06	9.42	3.73	10.35	2.90	3.31	0.62
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	48.80	9.30	1.71	16.33	5.51	0.19	0.57
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	21.32	10.83	1.75	12.58	3.49	1.40	0.00
squamous cell carcinoma cell line:T3M-5	10616-108G4	18.76	5.86	2.35	17.59	1.95	0.78	0.78
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	16.10	4.95	2.93	7.20	1.46	0.23	1.13
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	38.55	9.32	0.85	20.76	3.39	2.12	0.85
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	46.96	8.88	5.08	22.00	2.12	0.42	1.27
stomach, fetal, donor1	10062-101H8	42.72	5.34	4.27	6.41	1.07	0.00	0.00
submaxillary gland, adult	10202-103F4	16.52	6.27	2.28	16.52	1.14	2.28	0.00
substantia nigra - adult, donor10196	10178-103C7	0.00	0.00	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	5.61	3.12	2.28	3.53	1.87	0.42	0.21
substantia nigra, adult, donor10258	10371-105G2	3.10	3.62	0.00	11.38	2.59	0.00	0.00
substantia nigra, newborn, donor10223	10358-105E7	9.89	3.53	1.41	11.31	0.71	0.00	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	36.22	36.22	7.11	6.19	5.04	14.21	1.83
temporal lobe, adult, pool1	10031-101E4	5.34	4.49	1.36	1.10	2.03	1.95	0.85
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	11.40	9.26	4.27	2.14	3.56	0.71	1.42
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	6.59	6.15	1.32	5.71	3.08	3.96	0.44
tenocyte, donor1	11763-123H8	97.05	33.86	13.96	27.23	4.89	5.93	3.49
tenocyte, donor2	11765-123I1	62.95	14.12	8.77	18.69	2.67	7.63	2.29
tenocyte, donor3	11768-123I4	65.61	25.21	12.60	34.10	3.34	3.71	1.48
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	26.68	13.77	7.65	6.46	4.25	2.04	1.19
teratocarcinoma cell line:NCR-G1	10798-110I6	23.43	4.62	6.32	5.24	0.46	1.85	0.46
teratocarcinoma cell line:PA-1	10807-111A6	38.74	9.30	11.78	13.95	3.25	4.34	0.93
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	59.41	13.08	15.49	21.45	2.03	3.68	2.92
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	42.36	6.43	3.78	25.34	5.67	2.65	0.38
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	30.65	6.33	4.47	12.54	2.07	0.44	0.65
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	25.08	22.15	3.26	7.17	12.05	0.98	1.63
testis, adult, pool1	10026-101D8	27.06	3.65	1.50	5.37	2.25	1.40	0.11
testis, adult, pool2	10096-102C6	12.18	3.16	0.00	4.96	1.80	0.00	1.35
thalamus - adult, donor10196	10168-103B6	4.42	0.00	2.21	2.21	2.21	0.00	0.00
thalamus, adult, donor10252	10154-103A1	7.19	5.00	0.47	2.81	2.50	0.63	0.78
thalamus, adult, donor10258, tech_rep1	10370-105G1	1.54	4.62	0.00	1.54	1.54	1.54	1.54
thalamus, adult, donor10258, tech_rep2	10370-105G1	5.76	3.79	0.33	2.14	1.65	0.66	0.00
thalamus, newborn, donor10223	10366-105F6	6.90	1.73	0.00	4.60	1.15	1.15	0.00
throat, adult	10209-103G2	9.99	2.75	0.50	3.75	1.25	0.75	0.50
throat, fetal, donor1	10061-101H7	33.21	8.23	2.74	8.53	1.83	0.91	0.91
thymic carcinoma cell line:Ty-82	10803-111A2	27.62	28.62	6.56	5.17	7.95	11.13	1.79
thymus, adult, pool1	10027-101D9	4.18	2.19	1.29	0.70	0.99	1.39	0.60
thymus, fetal, pool1	10043-101F7	7.07	1.87	0.94	1.56	0.94	1.04	0.83
thyroid carcinoma cell line:KHM-5M	10776-110G2	76.45	11.43	5.85	21.94	3.19	3.86	0.66
thyroid carcinoma cell line:TCO-1	10783-110G9	51.27	17.18	9.64	17.60	4.05	2.10	2.10
thyroid, adult, pool1	10028-101E1	22.02	6.44	1.49	7.37	2.52	0.65	1.03
thyroid, fetal, donor1	10060-101H6	21.09	8.44	2.64	5.27	2.11	1.05	0.00
tongue epidermis (fungiform papillae), donor1	10288-104F9	15.40	3.08	0.00	0.00	0.00	0.00	0.00
tongue, adult	10203-103F5	8.37	1.16	0.47	3.49	0.47	0.00	0.23
tongue, fetal, donor1	10059-101H5	26.80	5.52	1.97	5.52	1.58	1.18	0.39
tonsil, adult, pool1	10047-101G2	11.12	1.20	0.40	2.10	0.80	1.00	0.00
trachea, adult, pool1	10029-101E2	29.37	3.93	0.90	9.49	2.45	1.23	0.33
trachea, fetal, donor1	10058-101H4	36.93	10.00	3.08	6.92	1.92	3.46	1.15
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	68.73	15.94	6.02	21.97	3.19	4.96	1.06
transitional-cell carcinoma cell line:5637	10418-106C4	50.25	9.52	5.78	13.88	4.36	3.65	1.22
transitional-cell carcinoma cell line:JMSU1	10492-107B6	44.81	12.06	5.95	7.83	4.86	2.82	1.88
tridermal teratoma cell line:HGRT	10694-109G1	72.30	11.42	7.61	19.03	1.90	5.71	3.81
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	37.67	3.13	2.45	10.24	1.69	0.51	0.17
umbilical cord, fetal, donor1	10057-101H3	60.51	8.35	14.61	12.52	4.17	4.17	2.09
uterus, adult, pool1	10100-102D1	29.01	8.02	1.19	9.04	4.27	4.78	1.02
uterus, fetal, donor1	10055-101H1	75.77	28.16	10.24	13.31	3.58	9.21	4.10
vagina, adult	10204-103F6	32.31	3.23	0.65	16.15	2.58	0.65	0.65
vein, adult	10191-103E2	14.47	1.53	1.97	4.16	1.75	0.44	0.22
xeroderma pigentosum b cell line:XPL 17	10563-108A5	7.74	6.41	3.47	4.54	2.40	2.94	0.27